

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The science of safety: complications associated... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-794/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-794" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety" />
    
            <meta name="og:title" content="F1000Research Article: The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety.">
            <meta name="og:description" content="Read the latest article version by Navin K. Kapur, Evan H. Whitehead, Katherine L. Thayer, Mohit Pahuja, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="28160">
            <meta name="article-id" content="25518">
            <meta name="dc.title" content="The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety">
            <meta name="dc.description" content="Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients.">
            <meta name="dc.subject" content="Safety review, cardiogenic shock, acute mechanical circulatory support, impella, ecmo, intraaortic balloon pump">
            <meta name="dc.creator" content="Kapur, Navin K.">
            <meta name="dc.creator" content="Whitehead, Evan H.">
            <meta name="dc.creator" content="Thayer, Katherine L.">
            <meta name="dc.creator" content="Pahuja, Mohit">
            <meta name="dc.date" content="2020/07/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.25518.1">
            <meta name="dc.source" content="F1000Research 2020 9:794">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Safety review">
            <meta name="prism.keyword" content="cardiogenic shock">
            <meta name="prism.keyword" content="acute mechanical circulatory support">
            <meta name="prism.keyword" content="impella">
            <meta name="prism.keyword" content="ecmo">
            <meta name="prism.keyword" content="intraaortic balloon pump">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/07/29">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="794">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.25518.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-794">
            <meta name="citation_title" content="The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety">
            <meta name="citation_abstract" content="Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients.">
            <meta name="citation_description" content="Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients.">
            <meta name="citation_keywords" content="Safety review, cardiogenic shock, acute mechanical circulatory support, impella, ecmo, intraaortic balloon pump">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Navin K. Kapur">
            <meta name="citation_author_institution" content="The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA">
            <meta name="citation_author" content="Evan H. Whitehead">
            <meta name="citation_author_institution" content="The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA">
            <meta name="citation_author" content="Katherine L. Thayer">
            <meta name="citation_author_institution" content="The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA">
            <meta name="citation_author" content="Mohit Pahuja">
            <meta name="citation_author_institution" content="Division of Cardiology, Detroit Medical Center/Wayne State University School of Medicine, Detroit, MI, USA">
            <meta name="citation_publication_date" content="2020/07/29">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="794">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.25518.1">
            <meta name="citation_firstpage" content="794">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-794/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-794.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=28160 /> <input type=hidden id=articleId name=articleId value=25518 /> <input type=hidden id=xmlUrl value="/articles/9-794/v1/xml"/> <input type=hidden id=xmlFileName value="-9-794-v1.xml"> <input type=hidden id=article_uuid value=11878dba-7d9e-4da4-8e52-d5a628719075 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.25518.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.25518.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-794"
  },
  "headline": "The science of safety: complications associated with the use of mechanical circulatory support in...",
  "datePublished": "2020-07-29T16:37:36",
  "dateModified": "2020-07-29T16:37:36",
  "author": [
    {
      "@type": "Person",
      "name": "Navin K. Kapur"
    },    {
      "@type": "Person",
      "name": "Evan H. Whitehead"
    },    {
      "@type": "Person",
      "name": "Katherine L. Thayer"
    },    {
      "@type": "Person",
      "name": "Mohit Pahuja"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-794/v1",
            "name": "The science of safety: complications associated with the use of mechanical..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The science of safety: complications associated with the use of mechanical... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=28160 data-id=25518 data-downloads="" data-views="" data-scholar="10.12688/f1000research.25518.1" data-recommended="" data-doi="10.12688/f1000research.25518.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-794/v1/pdf?article_uuid=11878dba-7d9e-4da4-8e52-d5a628719075" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-25518-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-25518-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-25518-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Kapur NK, Whitehead EH, Thayer KL and Pahuja M. The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):794 (<a class=new-orange href="https://doi.org/10.12688/f1000research.25518.1" target=_blank>https://doi.org/10.12688/f1000research.25518.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-25518-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=25518 id=track-article-signin-25518 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/25518?target=/articles/9-794/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=28160 /> <input name=articleId type=hidden value=25518 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:nkapur@tuftsmedicalcenter.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Navin K. Kapur</span></a><a href="https://orcid.org/0000-0002-8302-6796" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8302-6796</div><sup>1</sup>,&nbsp;</span><span class="">Evan H. Whitehead<sup>1</sup>,&nbsp;</span><span class="">Katherine L. Thayer<sup>1</sup>,&nbsp;</span><span class="">Mohit Pahuja<a href="https://orcid.org/0000-0002-7276-710X" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7276-710X</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:nkapur@tuftsmedicalcenter.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Navin K. Kapur</span></a><a href="http://orcid.org/0000-0002-8302-6796" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8302-6796</div><sup>1</sup>,&nbsp;</span><span class="">Evan H. Whitehead<sup>1</sup>,&nbsp;</span><span class="">Katherine L. Thayer<sup>1</sup>,&nbsp;</span><span class="">Mohit Pahuja<a href="http://orcid.org/0000-0002-7276-710X" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7276-710X</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Jul 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.25518.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA<br/> <sup>2</sup> Division of Cardiology, Detroit Medical Center/Wayne State University School of Medicine, Detroit, MI, USA<br/> <p> <div class=margin-bottom> Navin K. Kapur <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing </div> <div class=margin-bottom> Evan H. Whitehead <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Resources, Writing – Original Draft Preparation </div> <div class=margin-bottom> Katherine L. Thayer <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Mohit Pahuja <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=72301-67458></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=72302-67459></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Safety review, cardiogenic shock, acute mechanical circulatory support, impella, ecmo, intraaortic balloon pump </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Navin K. Kapur (<a href="mailto:nkapur@tuftsmedicalcenter.org">nkapur@tuftsmedicalcenter.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Navin K. Kapur </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> NKK receives consulting/speaker honoraria and institutional grant support from Abbott Laboratories, Abiomed Inc., Boston Scientific, Medtronic, LivaNova, MDStart, and Precardia. EHW, KLT and MP have no competing interests to report. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Kapur NK <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Kapur NK, Whitehead EH, Thayer KL and Pahuja M. The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):794 (<a href="https://doi.org/10.12688/f1000research.25518.1" target=_blank>https://doi.org/10.12688/f1000research.25518.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Jul 2020, <b>9</b>(Faculty Rev):794 (<a href="https://doi.org/10.12688/f1000research.25518.1" target=_blank>https://doi.org/10.12688/f1000research.25518.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Jul 2020, <b>9</b>(Faculty Rev):794 (<a href="https://doi.org/10.12688/f1000research.25518.1" target=_blank>https://doi.org/10.12688/f1000research.25518.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d17791e179>Acute mechanical circulatory support in cardiogenic shock</h2><p class="" id=d17791e182>Cardiogenic shock (CS) is an advanced state of hemodynamic compromise representing a convergent endpoint of cardiac decompensation resulting from acute myocardial infarction, end-stage heart failure, myocarditis, and various other conditions. In-hospital mortality in CS remains unacceptably high, with recent estimates ranging from 27–51%<sup><a href="#ref-1">1</a></sup>. Historically, CS has been managed largely with intravenous inotropes and vasopressors, medications which improve systemic perfusion at the cost of worsening myocardial supply/demand imbalance. Despite seeming to temporarily improve hemodynamic indices and traditional markers of tissue perfusion, empiric studies have shown that escalating inotropes and vasopressors fail to meaningfully reverse the downward hemodynamic spiral that occurs in CS, with very poor survival observed in patients requiring multiple agents<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d17791e193>Mechanical circulatory support (MCS) devices are commonly used to augment cardiac output and decouple systemic perfusion from native myocardial energy expenditure in CS. The intra-aortic balloon pump (IABP) was first applied in CS in the late 1960s, promising to improve hemodynamics through balloon counterpulsation synchronized with the cardiac cycle<sup><a href="#ref-3">3</a></sup>. The IABP became widely used and gained a class I indication for CS until the landmark IABP-SHOCK II trial showed that it failed to improve short- or long-term mortality in acute myocardial infarction complicated by CS (AMICS)<sup><a href="#ref-4">4</a>–<a href="#ref-6">6</a></sup>. Over the past decade, several other acute MCS platforms capable of providing much greater support have been developed and adopted to varying degrees in clinical practice. The trans-valvular axial flow pumps such as the Impella device (Abiomed, Danvers, MA) directly unload the left ventricle, capable of providing between 3 and 5.5 L/minute of flow while reducing native myocardial oxygen demand<sup><a href="#ref-7">7</a></sup>. A percutaneous right ventricular Impella device (Impella RP) is also available, which bypasses the right ventricle by displacing blood from the right atrium to pulmonary artery<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d17791e215>The TandemHeart device (CardiacAssist, Pittsburgh, PA) consists of a left atrial drainage cannula connected to an extracorporeal centrifugal flow pump, which returns blood to the descending aorta at flow rates of up to 5 L/minute<sup><a href="#ref-7">7</a></sup>. Because of the technical complexity and complications associated with the need for trans-septal puncture for delivery of the left atrial drainage cannula, the TandemHeart device is less commonly used in contemporary practice and thus will be only briefly discussed here. Finally, veno-arterial extracorporeal membrane oxygenation (VA-ECMO), a peripheral modification of cardiopulmonary bypass, is the only device which provides full systemic circulatory and respiratory support, though at the cost of increased left ventricular afterload<sup><a href="#ref-9">9</a></sup>. Recognizing the futility of escalating inotropes as well as the imperative to effectively intervene before impaired systemic perfusion progresses to an irreversible state of widespread metabolic failure, we and others have proposed CS management algorithms which incorporate early application of these advanced MCS platforms, with device selection tailored to the individual patient’s hemodynamic profile<sup><a href="#ref-10">10</a>–<a href="#ref-13">13</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17791e236>Putting recent safety signals into context</h2><p class="" id=d17791e239>All MCS devices are associated with risk. This risk is increased among patients in CS who are commonly treated with vasoconstrictive agents, anticoagulants, and anti-platelet drugs, and may be exposed to other devices requiring large bore access such as hemodialysis catheters, pulmonary artery catheters, and other venous or arterial sheaths for monitoring and drug delivery. Use of large-bore MCS access along with a requirement for systemic anticoagulation increases the risk for bleeding, limb ischemia, and stroke<sup><a href="#ref-14">14</a></sup>. Intravascular shear and varying degrees of hemocompatibility with non-biologic surfaces can induce hemolysis, which in combination with systemic inflammation and thromboembolism can predispose to renal failure, with significant prognostic implications<sup><a href="#ref-15">15</a></sup>. Understanding the relative risks of these various complications with different MCS devices and their implications for device selection in patients has been extremely challenging.</p><p class="" id=d17791e250>Straightforward comparison of complication rates across devices is possible only by using data from randomized trials in which equivalent patients are randomized to different device strategies. Complication rates observed in randomized trials performed to date are summarized in <a href="#T1">Table 1</a>. The IABP-SHOCK II trial was the largest randomized trial of an MCS device performed in CS to date and reported low rates of bleeding, limb ischemia, and stroke in both the IABP and medical therapy arms<sup><a href="#ref-4">4</a></sup>. Two small randomized trials comparing the TandemHeart device to IABP showed a clear signal toward higher rates of bleeding and limb ischemia with TandemHeart, though these trends were significant in only one of the two studies<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup>. Three small, underpowered randomized trials have been conducted evaluating the use of Impella in CS. The ISAR-SHOCK (Efficacy Study of LV Assist Device to Treat Patients with Cardiogenic Shock) trial was a small study (n = 25) comparing the early generation Impella 2.5 to IABP, powered for a surrogate endpoint of hemodynamic improvement 30 minutes after device insertion<sup><a href="#ref-18">18</a></sup>. A numerically higher incidence of bleeding, hemolysis, and limb ischemia was observed among Impella patients, though the sample was too small to evaluate the significance of these trends. The IMPRESS in Severe Shock (IMPella versus IABP Reduces mortality in STEMI patients treated with primary PCI in Severe cardiogenic SHOCK) trial was designed to compare all-cause mortality between IABP and the Impella CP in AMICS but ended up being completed as an exploratory safety trial because of miscalculation of expected event rates<sup><a href="#ref-19">19</a></sup>. A trend toward higher rates of bleeding and hemolysis was observed with the Impella CP, though the small sample size limited any conclusive findings. Finally, the IMPELLA-STIC trial compared IABP alone to IABP plus Impella 5.0 in 12 patients with AMICS and found a significantly higher rate of major bleeding in the combined device group, though the study was too small to evaluate the significance of other complication trends<sup><a href="#ref-20">20</a></sup>. To date, only one randomized trial has evaluated the use of VA-ECMO in CS: the Extracorporeal Life Support in cardiogenic Shock complicating acute myocardial infarction (ECLS-SHOCK) trial randomized 42 post-arrest AMICS patients to VA-ECMO or no MCS and found similar rates of complications between groups, though again the study was underpowered for clinical outcomes including safety conclusions<sup><a href="#ref-21">21</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Summary of MCS complication rates reported in randomized trials and comparative observational studies of acute MCS in CS.</h3><p id=d17791e294>AKI, acute kidney injury; AMICS, acute myocardial infarction complicated by cardiogenic shock; CS, cardiogenic shock; CVA, cerebrovascular accident; GI, gastrointestinal; GU, genitourinary; HgB, hemoglobin; IABP, intra-aortic balloon pump; MCS, mechanical circulatory support; n.s., not significant; OR, odds ratio; PCI, percutaneous coronary intervention; pRBCs, packed red blood cells; RU, rectal ulcer; TIA, transient ischemic attack; VA-ECMO, veno-arterial extracorporeal membrane oxygenation.</p></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d17791e298 class=n-a></a><thead><a name=d17791e300 class=n-a></a><tr><a name=d17791e302 class=n-a></a><th align=left colspan=1 rowspan=1 valign=middle><a name=d17791e304 class=n-a></a>Study</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e307 class=n-a></a>Comparison</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e310 class=n-a></a>Major bleeding</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e313 class=n-a></a>Stroke</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e316 class=n-a></a>AKI</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e320 class=n-a></a>Limb ischemia</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e323 class=n-a></a>Hemolysis</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e326 class=n-a></a>Sepsis</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e329 class=n-a></a>Death</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d17791e332 class=n-a></a>Perspective</th></tr></thead><tbody><a name=d17791e336 class=n-a></a><tr><a name=d17791e338 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e340 class=n-a></a>Thiele <i>et al</i>.<br class=br>(IABP-SHOCK-<br class=br>II)<sup><a href="#ref-4">4</a></sup></td><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e353 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e355 class=n-a></a><i>Life-threatening</i><br class=br><i>or severe and</i><br class=br><i>moderate</i><br class=br><i>bleeding as</i><br class=br><i>defined by</i><br class=br><i>GUSTO criteria</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e374 class=n-a></a><i>New</i><br class=br><i>neurologic</i><br class=br><i>symptoms in</i><br class=br><i>conjunction</i><br class=br><i>with signs of</i><br class=br><i>ischemia or</i><br class=br><i>hemorrhage</i><br class=br><i>on head CT</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e400 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e405 class=n-a></a><i>Peripheral</i><br class=br><i>ischemic vascular</i><br class=br><i>complication</i><br class=br><i>requiring surgical</i><br class=br><i>or interventional</i><br class=br><i>management</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e424 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e428 class=n-a></a><i>Sepsis with</i><br class=br><i>clinical signs</i><br class=br><i>of infection</i><br class=br><i>and elevated</i><br class=br><i>procalcitonin</i><br class=br><i>levels</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e447 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e454 class=n-a></a>•&nbsp;&nbsp;&nbsp;Poorly defined<br class=br>controls No<br class=br>definition of shock<br class=br>severity<br class=br>•&nbsp;&nbsp;&nbsp;Wide range of<br class=br>timing for IABP<br class=br>support initiation<br class=br>•&nbsp;&nbsp;&nbsp;No hemodynamic<br class=br>guidance for<br class=br>management of<br class=br>shock<br class=br>•&nbsp;&nbsp;&nbsp;1-year and 6-<br class=br>year mortality<br class=br>also assessed<br class=br>and showed no<br class=br>difference</td></tr><tr><a name=d17791e490 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e492 class=n-a></a>IABP<br class=br>(n = 301)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e497 class=n-a></a>Life-threatening:<br class=br>3.3% Moderate:<br class=br>17.3%</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e504 class=n-a></a>0.7% (2/300)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e507 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e510 class=n-a></a>4.3% (13/300)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e514 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e517 class=n-a></a>15.6% (47/300)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e520 class=n-a></a>39.70%</td></tr><tr><a name=d17791e524 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e526 class=n-a></a>Medical therapy<br class=br>(n = 299)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e531 class=n-a></a>Life-<br class=br>threatening:<br class=br>4.4% Moderate:<br class=br>16.4%</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e540 class=n-a></a>1.7% (5/298)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e543 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e546 class=n-a></a>3.4% (10/298)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e550 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e553 class=n-a></a>20.5% (61/298)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e556 class=n-a></a>41.30%</td></tr><tr><a name=d17791e560 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e562 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e567 class=n-a></a>0.51</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e570 class=n-a></a>0.28</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e573 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e576 class=n-a></a>0.53</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e580 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e583 class=n-a></a>0.15</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e586 class=n-a></a>0.69</td></tr><tr><a name=d17791e590 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e592 class=n-a></a>Thiele <i>et al</i>.<sup><a href="#ref-16">16</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e601 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e603 class=n-a></a><i>Major bleeding</i><br class=br><i>requiring</i><br class=br><i>transfusion</i><br class=br><i>of blood</i><br class=br><i>components</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e619 class=n-a></a><i>CVA with</i><br class=br><i>neurological</i><br class=br><i>dysfunction</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e629 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e634 class=n-a></a><i>Lower extremity</i><br class=br><i>ischemia requiring</i><br class=br><i>surgical or</i><br class=br><i>interventional action</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e647 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e651 class=n-a></a><i>Elevated body</i><br class=br><i>temperature</i><br class=br><i>&gt;38.5°C</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e661 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e668 class=n-a></a>•&nbsp;&nbsp;&nbsp;Surrogate primary<br class=br>endpoint<br class=br>•&nbsp;&nbsp;&nbsp;Not sufficiently<br class=br>powered to assess<br class=br>mortality<br class=br>•&nbsp;&nbsp;&nbsp;AMICS only<br class=br>•&nbsp;&nbsp;&nbsp;MCS implantation was<br class=br>prior or post PCI</td></tr><tr><a name=d17791e688 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e690 class=n-a></a>IABP<br class=br>(n = 20)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e695 class=n-a></a>40% (8/20)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e698 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e701 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e704 class=n-a></a>0% (0/20)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e708 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e711 class=n-a></a>50% (10/20)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e714 class=n-a></a>45%</td></tr><tr><a name=d17791e718 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e720 class=n-a></a>Tandem (n =<br class=br>21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e725 class=n-a></a>90.5% (19/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e728 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e731 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e734 class=n-a></a>33.3% (7/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e738 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e741 class=n-a></a>81% (17/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e744 class=n-a></a>43%</td></tr><tr><a name=d17791e748 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e750 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e755 class=n-a></a>0.002</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e758 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e761 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e764 class=n-a></a>0.009</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e768 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e771 class=n-a></a>0.08</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e774 class=n-a></a>0.86</td></tr><tr><a name=d17791e778 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e780 class=n-a></a>Burkhoff<br class=br><i>et al</i>.<sup><a href="#ref-17">17</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e790 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e792 class=n-a></a><i>Bleeding</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e796 class=n-a></a><i>Neurologica</i><br class=br><i>dysfunction</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e803 class=n-a></a><i>Renal</i><br class=br><i>dysfunction</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e811 class=n-a></a><i>Distal leg ischemia</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e815 class=n-a></a><i>Plasma free Hgb &gt;40</i><br class=br><i>mg/dL two or more</i><br class=br><i>measurements taken</i><br class=br><i>8 hours apart</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e828 class=n-a></a><i>Systemic infection</i><br class=br><i>or sepsis</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e835 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e842 class=n-a></a>•&nbsp;&nbsp;&nbsp;Surrogate primary<br class=br>endpoint<br class=br>•&nbsp;&nbsp;&nbsp;Trial ended<br class=br>prematurely<br class=br>•&nbsp;&nbsp;&nbsp;Did not exclude<br class=br>patients with IABP<br class=br>already placed at time<br class=br>of enrollment</td></tr><tr><a name=d17791e861 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e863 class=n-a></a>IABP<br class=br>(n = 14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e868 class=n-a></a>14.3% (2/14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e871 class=n-a></a>50% (7/14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e874 class=n-a></a>21.4% (3/14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e877 class=n-a></a>14.3% (2/14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e881 class=n-a></a>7.1% (1/14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e884 class=n-a></a>35.7% (5/14)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e887 class=n-a></a>64%</td></tr><tr><a name=d17791e891 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e893 class=n-a></a>Tandem (n =<br class=br>19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e898 class=n-a></a>42.1% (8/19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e901 class=n-a></a>31.6% (6/19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e904 class=n-a></a>21.5% (4/19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e907 class=n-a></a>21.5% (4/19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e911 class=n-a></a>5.3% (1/19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e914 class=n-a></a>21% (4/19)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e917 class=n-a></a>53%</td></tr><tr><a name=d17791e922 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e924 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e929 class=n-a></a>0.13</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e932 class=n-a></a>0.47</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e935 class=n-a></a>0.99</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e938 class=n-a></a>0.99</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e942 class=n-a></a>0.99</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e945 class=n-a></a>0.44</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e948 class=n-a></a>n.s</td></tr><tr><a name=d17791e952 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e954 class=n-a></a>Seyfarth<br class=br><i>et al</i>. (ISAR-<br class=br>SHOCK)<sup><a href="#ref-18">18</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e966 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e968 class=n-a></a><i>Units of pRBCs</i><br class=br><i>administered</i><br class=br><i>per patient</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e978 class=n-a></a><i>Survival</i><br class=br><i>without</i><br class=br><i>neurologic</i><br class=br><i>deficit</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e991 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e996 class=n-a></a><i>Acute limb ischemia</i><br class=br><i>requiring surgery</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1003 class=n-a></a><i>Time course of free</i><br class=br><i>HgB</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1010 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1014 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1021 class=n-a></a>•&nbsp;&nbsp;&nbsp;Not powered fo<br class=br>mortality<br class=br>•&nbsp;&nbsp;&nbsp;AMICS only<br class=br>•&nbsp;&nbsp;&nbsp;Impella 2.5 does not<br class=br>provide complete<br class=br>support and may not<br class=br>be an appropriate<br class=br>comparison to IABP<br class=br>•&nbsp;&nbsp;&nbsp;Definition of major<br class=br>bleeding makes it<br class=br>difficult to compare<br class=br>to other studies<br class=br>•&nbsp;&nbsp;&nbsp;Safety outcomes<br class=br>were not well<br class=br>reported<br class=br>•&nbsp;&nbsp;&nbsp;Outcomes of patients<br class=br>who died prior to<br class=br>intervention were<br class=br>included in analysis</td></tr><tr><a name=d17791e1064 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1066 class=n-a></a>IABP<br class=br>(n = 13)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1071 class=n-a></a>1.2 U</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1074 class=n-a></a>30.8% (4/13)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1077 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1080 class=n-a></a>0% (0/13)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1084 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1087 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1090 class=n-a></a>46.20%</td></tr><tr><a name=d17791e1094 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1096 class=n-a></a>Impella 2.5 (n<br class=br>= 12)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1101 class=n-a></a>2.6 U</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1104 class=n-a></a>50% (6/12)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1107 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1110 class=n-a></a>8.3% (1/12)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1114 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1117 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1120 class=n-a></a>50%</td></tr><tr><a name=d17791e1124 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1126 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1131 class=n-a></a>0.18</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1134 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1137 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1140 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1144 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1147 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1150 class=n-a></a>Not<br class=br>reported</td></tr><tr><a name=d17791e1156 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1158 class=n-a></a>Ouweneel<br class=br><i>et al</i>.<br class=br>(IMPRESS)<sup><a href="#ref-19">19</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1170 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1172 class=n-a></a><i>Serum Hgb</i><br class=br><i>drop of 5 g/dL</i><br class=br><i>or transfusion</i><br class=br><i>of two units</i><br class=br><i>of pRBCs</i><br class=br><i>or surgery</i><br class=br><i>to control</i><br class=br><i>bleeding</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1198 class=n-a></a><i>Any stroke</i><br class=br><i>confirmed by</i><br class=br><i>neurologist</i><br class=br><i>and CT scan</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1211 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1216 class=n-a></a><i>Major bleed at</i><br class=br><i>arterial access site</i><br class=br><i>requiring device</i><br class=br><i>extraction or</i><br class=br><i>thrombotic occlusion</i><br class=br><i>of femoral artery</i><br class=br><i>or limb ischemia</i><br class=br><i>requiring device</i><br class=br><i>extraction or need</i><br class=br><i>for vascular surgery</i><br class=br><i>to correct vascular</i><br class=br><i>complication</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1255 class=n-a></a><i>Evidence of clinically</i><br class=br><i>relevant hemolysis</i><br class=br><i>requiring device</i><br class=br><i>extraction</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1268 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1272 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1279 class=n-a></a>•&nbsp;&nbsp;&nbsp;Underpowered due<br class=br>to poor estimation of<br class=br>true mortality rate<br class=br>•&nbsp;&nbsp;&nbsp;Study cohort not<br class=br>appropriate for<br class=br>treatment evaluation;<br class=br>single MCS<br class=br>intervention alone<br class=br>is unlikely to benefit<br class=br>severe CS patients<br class=br>•&nbsp;&nbsp;&nbsp;No safety <i>p</i> values<br class=br>reported so<br class=br>difficult to assess<br class=br>comparison</td></tr><tr><a name=d17791e1315 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1317 class=n-a></a>IABP<br class=br>(n = 24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1322 class=n-a></a>8.3% (2/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1325 class=n-a></a>4.2% (1/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1328 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1331 class=n-a></a>0% (0/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1335 class=n-a></a>0% (0/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1338 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1341 class=n-a></a>50%</td></tr><tr><a name=d17791e1345 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1347 class=n-a></a>Impella CP (n<br class=br>= 24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1352 class=n-a></a>33.3% (8/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1355 class=n-a></a>4.2% (1/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1358 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1361 class=n-a></a>4.2% (1/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1365 class=n-a></a>33.3% (8/24)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1368 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1371 class=n-a></a>45.80%</td></tr><tr><a name=d17791e1375 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1377 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1382 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1385 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1388 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1391 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1395 class=n-a></a>Not reported</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1398 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1401 class=n-a></a>0.92</td></tr><tr><a name=d17791e1405 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1407 class=n-a></a>Bochaton<br class=br><i>et al</i>.<br class=br>(IMPELLA-<br class=br>STIC)<sup><a href="#ref-20">20</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1421 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1423 class=n-a></a><i>Major bleeding</i><br class=br><i>requiring</i><br class=br><i>transfusion</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1433 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1437 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1442 class=n-a></a><i>Limb complication</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1446 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1450 class=n-a></a><i>Sepsis</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1454 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1461 class=n-a></a>•&nbsp;&nbsp;&nbsp;Severely inadequate<br class=br>sample size due to<br class=br>slow enrollment<br class=br>•&nbsp;&nbsp;&nbsp;Compounding effect<br class=br>of having IABP in<br class=br>both arms<br class=br>•&nbsp;&nbsp;&nbsp;Vague definitions of<br class=br>safety outcomes</td></tr><tr><a name=d17791e1479 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1481 class=n-a></a>IABP<br class=br>(n = 6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1486 class=n-a></a>0% (0/6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1489 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1492 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1495 class=n-a></a>0% (0/6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1499 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1502 class=n-a></a>50% (3/6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1505 class=n-a></a>0%</td></tr><tr><a name=d17791e1509 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1511 class=n-a></a>IABP + Impella<br class=br>5.0 (n = 6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1516 class=n-a></a>83.3% (5/6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1519 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1522 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1525 class=n-a></a>33.3% (2/6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1529 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1532 class=n-a></a>83.3% (5/6)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1535 class=n-a></a>33.30%</td></tr><tr><a name=d17791e1540 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1542 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1547 class=n-a></a>0.02</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1550 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1553 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1556 class=n-a></a>0.46</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1560 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1563 class=n-a></a>0.59</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1566 class=n-a></a>0.46</td></tr><tr><a name=d17791e1570 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1572 class=n-a></a>Schrage <i>et al</i>.<sup><a href="#ref-24">24</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1581 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1583 class=n-a></a><i>Life-threatening</i><br class=br><i>or severe and</i><br class=br><i>moderate</i><br class=br><i>bleeding as</i><br class=br><i>defined by</i><br class=br><i>GUSTO criteria</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1602 class=n-a></a><i>New</i><br class=br><i>neurologic</i><br class=br><i>symptoms in</i><br class=br><i>conjunction</i><br class=br><i>with signs of</i><br class=br><i>ischemia or</i><br class=br><i>hemorrhage</i><br class=br><i>on head CT</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1628 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1633 class=n-a></a><i>Peripheral</i><br class=br><i>ischemic vascular</i><br class=br><i>complication</i><br class=br><i>requiring surgical</i><br class=br><i>or interventional</i><br class=br><i>management</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1652 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1656 class=n-a></a><i>Sepsis with</i><br class=br><i>clinical signs</i><br class=br><i>of infection</i><br class=br><i>and elevated</i><br class=br><i>procalcitonin</i><br class=br><i>levels</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1675 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e1682 class=n-a></a>•&nbsp;&nbsp;&nbsp;Non-randomized study<br class=br>•&nbsp;&nbsp;&nbsp;Included Impella 2.5<br class=br>and Impella CP<br class=br>•&nbsp;&nbsp;&nbsp;Only 38.1% of<br class=br>Impellas were<br class=br>implanted prior to<br class=br>PCI<br class=br>•&nbsp;&nbsp;&nbsp;Poorly defined<br class=br>control group</td></tr><tr><a name=d17791e1702 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1704 class=n-a></a>No Impella (n =<br class=br>237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1709 class=n-a></a>Life-<br class=br>threatening:<br class=br>3.0% Moderate:<br class=br>16.9%</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1718 class=n-a></a>2.5% (6/237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1721 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1724 class=n-a></a>3.8% (9/237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1728 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1731 class=n-a></a>19.4% (46/237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1734 class=n-a></a>46.40%</td></tr><tr><a name=d17791e1738 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1740 class=n-a></a>Impella 2.5/CP<br class=br>(n = 237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1745 class=n-a></a>Life-<br class=br>threatening:<br class=br>8.4%<br class=br>Moderate:<br class=br>20.3%</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1756 class=n-a></a>2.5% (6/237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1759 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1762 class=n-a></a>9.7% (23/237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1766 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1769 class=n-a></a>30.8% (73/237)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1772 class=n-a></a>48.50%</td></tr><tr><a name=d17791e1776 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1778 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1783 class=n-a></a>Life-<br class=br>threatening:<br class=br>&lt;0.01<br class=br>Moderate: 0.32</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1792 class=n-a></a>0.76</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1795 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1798 class=n-a></a>0.01</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1802 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1805 class=n-a></a>&lt;0.01</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1808 class=n-a></a>0.64</td></tr><tr><a name=d17791e1812 class=n-a></a><td align=left colspan=1 rowspan=2 valign=middle><a name=d17791e1814 class=n-a></a>Amin <i>et al</i>.<sup><a href="#ref-25">25</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1823 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1825 class=n-a></a><i>Bleeding</i><br class=br><i>event requiring</i><br class=br><i>transfusion</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1835 class=n-a></a><i>Ischemic</i><br class=br><i>stroke,</i><br class=br><i>hemorrhagic</i><br class=br><i>stroke,</i><br class=br><i>intracerebral</i><br class=br><i>hemorrhage,</i><br class=br><i>or TIA</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1858 class=n-a></a><i>AKI</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1863 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1867 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1871 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1875 class=n-a></a><i>In-hospital</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=2 valign=middle><a name=d17791e1882 class=n-a></a>•&nbsp;&nbsp;&nbsp;Observational study<br class=br>•&nbsp;&nbsp;&nbsp;Did not control for<br class=br>many parameters<br class=br>that may affect<br class=br>association with<br class=br>mortality<br class=br>•&nbsp;&nbsp;&nbsp;Only reported ORs,<br class=br>no absolute values to<br class=br>assess actual effect</td></tr><tr><a name=d17791e1904 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e1906 class=n-a></a>Impella (4,782)<br class=br>versus IABP<br class=br>(43,524),<br class=br>propensity<br class=br>matched</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1917 class=n-a></a>OR: 1.10<br class=br>(1.0–1.21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1922 class=n-a></a>OR: 1.34<br class=br>(1.18–1.53)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1927 class=n-a></a>OR: 1.08<br class=br>(1.0–1.17)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1932 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1936 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1939 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1942 class=n-a></a>OR: 1.24<br class=br>(1.13–1.36)</td></tr><tr><a name=d17791e1948 class=n-a></a><td align=left colspan=1 rowspan=7 valign=middle><a name=d17791e1950 class=n-a></a>Dhruva <i>et al</i>.<sup><a href="#ref-26">26</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1959 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e1961 class=n-a></a><i>Hgb drop &lt;3 g/</i><br class=br><i>dL, transfusion</i><br class=br><i>of whole blood</i><br class=br><i>or pRBCs,</i><br class=br><i>procedural</i><br class=br><i>intervention to</i><br class=br><i>treat bleeding,</i><br class=br><i>or transfusion</i><br class=br><i>of whole blood</i><br class=br><i>or packed</i><br class=br><i>red blood, or</i><br class=br><i>suspected</i><br class=br><i>GI, GU, RP, or</i><br class=br><i>other bleed</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2006 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2010 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2015 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2019 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2023 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2027 class=n-a></a><i>In-hospital</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=7 valign=middle><a name=d17791e2034 class=n-a></a>•&nbsp;&nbsp;&nbsp;Observational study<br class=br>•&nbsp;&nbsp;&nbsp;Crude imputation of<br class=br>missing registry data<br class=br>•&nbsp;&nbsp;&nbsp;Patients with multiple<br class=br>PCIs included<br class=br>in study and not<br class=br>accounted for<br class=br>•&nbsp;&nbsp;&nbsp;Minimal safety<br class=br>outcome assessment<br class=br>•&nbsp;&nbsp;&nbsp;Did not control for<br class=br>many parameters<br class=br>that may affect<br class=br>association with<br class=br>mortality</td></tr><tr><a name=d17791e2065 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2067 class=n-a></a>Impella (n =<br class=br>1,680)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2072 class=n-a></a>31.3%<br class=br>(526/1,680)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2077 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2080 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2083 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2087 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2090 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2093 class=n-a></a>45.0%</td></tr><tr><a name=d17791e2097 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2099 class=n-a></a>IABP (n = 1680)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2102 class=n-a></a>16.0%<br class=br>(268/1,680)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2107 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2110 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2113 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2117 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2120 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2123 class=n-a></a>34.1%</td></tr><tr><a name=d17791e2127 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2129 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2134 class=n-a></a>&lt;0.001</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2137 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2140 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2143 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2147 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2150 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2153 class=n-a></a>&lt;0.001</td></tr><tr><a name=d17791e2157 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2159 class=n-a></a>IABP (n <br class=br>= 7,805)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2164 class=n-a></a>14.5%</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2167 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2170 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2173 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2177 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2180 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2183 class=n-a></a>28.6%</td></tr><tr><a name=d17791e2188 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2190 class=n-a></a>No device (n =<br class=br>7,805)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2195 class=n-a></a>11.0%</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2198 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2201 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2204 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2208 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2211 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2214 class=n-a></a>26.5%</td></tr><tr><a name=d17791e2218 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2220 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2225 class=n-a></a>&lt;0.001</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2228 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2231 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2234 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2238 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2241 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2244 class=n-a></a>0.002</td></tr><tr><a name=d17791e2248 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e2250 class=n-a></a>Brunner<br class=br><i>et al</i>.<br class=br>(ECLS-<br class=br>SHOCK)<sup><a href="#ref-21">21</a></sup></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2264 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2266 class=n-a></a><i>Life-</i><br class=br><i>threatening,</i><br class=br><i>severe, or</i><br class=br><i>moderate</i><br class=br><i>bleeding</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2282 class=n-a></a><i>Stroke</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2286 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2291 class=n-a></a><i>Peripheral</i><br class=br><i>ischemic vascular</i><br class=br><i>complication</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2301 class=n-a></a><i>x</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2305 class=n-a></a><i>Sepsis</i></td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2309 class=n-a></a><i>30-day</i><br class=br><i>mortality</i></td><td align=left colspan=1 rowspan=4 valign=middle><a name=d17791e2316 class=n-a></a>Study is not well<br class=br>described, particularly<br class=br>control group definition,<br class=br>and may not be an<br class=br>appropriate comparator </td></tr><tr><a name=d17791e2327 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2329 class=n-a></a>No MCS (21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2332 class=n-a></a>14.3% (3/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2335 class=n-a></a>4.8% (1/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2338 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2341 class=n-a></a>0% (0/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2345 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2348 class=n-a></a>33.3% (7/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2351 class=n-a></a>19%</td></tr><tr><a name=d17791e2355 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2357 class=n-a></a>VA-ECMO (21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2360 class=n-a></a>19.0% (4/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2363 class=n-a></a>4.8% (1/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2366 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2369 class=n-a></a>9.5% (2/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2373 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2376 class=n-a></a>42.9% (9/21)</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2379 class=n-a></a>33.30%</td></tr><tr><a name=d17791e2383 class=n-a></a><td align=left colspan=1 rowspan=1 valign=middle><a name=d17791e2385 class=n-a></a><i>P</i> value</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2390 class=n-a></a>1.0</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2393 class=n-a></a>1.0</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2396 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2399 class=n-a></a>0.49</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2403 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2406 class=n-a></a>0.75</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d17791e2409 class=n-a></a>0.37</td></tr></tbody></table></div><p class="" id=d17791e2416>Given the paucity of sufficiently powered randomized trials, most data on complication rates come from observational case series and registries, which are summarized in <a href="#T2">Table 2</a>. Despite inconsistent reporting and variability in outcome definitions, several trends are apparent from these data. First, higher rates of bleeding and vascular injury are associated with devices requiring larger bore access including Impella (13–14 French access sheaths) and VA-ECMO (21–27 French venous cannulas plus 15–21 French arterial cannulas) compared to IABP (8–9 French access). Similarly, rates of stroke and limb ischemia are increased with Impella compared with IABP, and higher still with VA-ECMO. Two recent analyses by Pahuja <i>et al.</i> comparing rates of stroke, bleeding, and limb ischemia among AMICS patients treated with IABP, percutaneous VADs (Impella or TandemHeart), or VA-ECMO are exemplary of these trends. In this large sample, stroke was observed in 3.1% of patients with IABP, 5.6% of those with pVADs, and 9.7% of those treated with VA-ECMO. Similarly, bleeding occurred in 19.4%, 29.9%, and 54.2% of each group, respectively, while limb ischemia occurred in 0.9%, 3.6%, and 7.7%, respectively. All of these complications were associated with increased length of stay and hospitalization costs<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. While it stands to reason that more invasive devices would lead to higher complication rates, it must be noted that these observational studies do not account for significant baseline differences between the real-world patients in whom the devices are deployed. Crude insight about the severity of shock across device cohorts can be gained by comparing the short-term mortality rates in <a href="#T2">Table 2</a>. The lowest mortality is observed in patients treated with IABP (24%), which may be related to the selection of patients with “less-severe” CS who do not require high levels of hemodynamic support. In contrast, higher flow devices such as Impella may be chosen for patients with more severe CS, as reflected in a significantly higher mortality rate of 43.1%. Finally, as it is the only device capable of providing both circulatory and respiratory support, VA-ECMO is often applied emergently for patients with cardiac arrest or severe CS, reflected in an extremely high observed mortality rate of 57.2%. Some of the observed disparity in complication rates across device cohorts may therefore be driven by baseline differences in illness severity, in addition to device factors. Accordingly, lower complication rates have been observed when these advanced devices have been applied in less-severely-ill cohorts. The recent STEMI-Door-to-Unload (STEMI-DTU) pilot trial tested the safety and feasibility of Impella CP use in 50 patients with anterior STEMI, without CS. In this cohort with 4% overall mortality, complication rates were quite low: bleeding occurred in 14%, stroke in 2%, renal dysfunction in 4%, and hemolysis in 2%<sup><a href="#ref-89">89</a></sup>. Two patients (4%) had major vascular events related to flow-limiting dissections of the femoral artery at device removal, with no device related mortality observed.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Complication rates associated with IABP, Impella, and VA-ECMO from observational studies in cardiogenic shock.</h3><p id=d17791e2450>Death represents either 30-day or in-hospital mortality, whichever was reported in the individual study. AKI, acute kidney injury; IABP, intra-aortic balloon pump; VA-ECMO, veno-arterial extracorporeal membrane oxygenation</p></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d17791e2454 class=n-a></a><thead><a name=d17791e2456 class=n-a></a><tr><a name=d17791e2458 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d17791e2460 class=n-a></a>IABP</th><th align=left colspan=1 rowspan=1><a name=d17791e2463 class=n-a></a>Study</th><th align=center colspan=1 rowspan=1><a name=d17791e2466 class=n-a></a>n</th><th align=center colspan=1 rowspan=1><a name=d17791e2469 class=n-a></a>Bleeding (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e2472 class=n-a></a>Stroke (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e2476 class=n-a></a>AKI (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e2479 class=n-a></a>Limb<br class=br>ischemia (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e2484 class=n-a></a>Hemolysis (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e2487 class=n-a></a>Sepsis (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e2490 class=n-a></a>Death (%)</th></tr></thead><tbody><a name=d17791e2495 class=n-a></a><tr><a name=d17791e2497 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2499 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2501 class=n-a></a>Tehrani <i>et al</i>.<sup><a href="#ref-10">10</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2510 class=n-a></a>55</td><td align=center colspan=1 rowspan=1><a name=d17791e2513 class=n-a></a>9.1</td><td align=center colspan=1 rowspan=1><a name=d17791e2516 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2520 class=n-a></a>23.6</td><td align=center colspan=1 rowspan=1><a name=d17791e2523 class=n-a></a>7.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2526 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2529 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2532 class=n-a></a>-</td></tr><tr><a name=d17791e2535 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2537 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2539 class=n-a></a>Alushi <i>et al</i>.<sup><a href="#ref-33">33</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2548 class=n-a></a>54</td><td align=center colspan=1 rowspan=1><a name=d17791e2551 class=n-a></a>7.4</td><td align=center colspan=1 rowspan=1><a name=d17791e2554 class=n-a></a>1.8</td><td align=center colspan=1 rowspan=1><a name=d17791e2558 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2561 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2564 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2567 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2570 class=n-a></a>52.0</td></tr><tr><a name=d17791e2573 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2575 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2577 class=n-a></a>Pieri <i>et al</i>.<sup><a href="#ref-34">34</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2586 class=n-a></a>36</td><td align=center colspan=1 rowspan=1><a name=d17791e2589 class=n-a></a>36.1</td><td align=center colspan=1 rowspan=1><a name=d17791e2592 class=n-a></a>8.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2596 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2599 class=n-a></a>2.8</td><td align=center colspan=1 rowspan=1><a name=d17791e2602 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2605 class=n-a></a>36.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2608 class=n-a></a>6.0</td></tr><tr><a name=d17791e2611 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2612 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2614 class=n-a></a>Ferguson <i>et al</i>.<sup><a href="#ref-35">35</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2623 class=n-a></a>16,909</td><td align=center colspan=1 rowspan=1><a name=d17791e2626 class=n-a></a>2.4</td><td align=center colspan=1 rowspan=1><a name=d17791e2629 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2632 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2636 class=n-a></a>2.9</td><td align=center colspan=1 rowspan=1><a name=d17791e2639 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2642 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2645 class=n-a></a>21.2</td></tr><tr><a name=d17791e2648 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2649 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2651 class=n-a></a>Cohen <i>et al</i>.<sup><a href="#ref-36">36</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2660 class=n-a></a>22,663</td><td align=center colspan=1 rowspan=1><a name=d17791e2663 class=n-a></a>0.9</td><td align=center colspan=1 rowspan=1><a name=d17791e2666 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2669 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2673 class=n-a></a>0.9</td><td align=center colspan=1 rowspan=1><a name=d17791e2676 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2679 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2682 class=n-a></a>21.3</td></tr><tr><a name=d17791e2686 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2687 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2689 class=n-a></a>Stone <i>et al</i>.<sup><a href="#ref-37">37</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2698 class=n-a></a>5,495</td><td align=center colspan=1 rowspan=1><a name=d17791e2701 class=n-a></a>4.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2704 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2707 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2711 class=n-a></a>2.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2714 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2717 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2720 class=n-a></a>20.0</td></tr><tr><a name=d17791e2723 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2724 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2726 class=n-a></a>Siriwardena <i>et al</i>.<sup><a href="#ref-38">38</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2735 class=n-a></a>645</td><td align=center colspan=1 rowspan=1><a name=d17791e2738 class=n-a></a>2.9</td><td align=center colspan=1 rowspan=1><a name=d17791e2741 class=n-a></a>2.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2744 class=n-a></a>16.6</td><td align=center colspan=1 rowspan=1><a name=d17791e2748 class=n-a></a>2.6</td><td align=center colspan=1 rowspan=1><a name=d17791e2751 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2754 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2757 class=n-a></a>-</td></tr><tr><a name=d17791e2760 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2761 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2763 class=n-a></a>Cohen <i>et al</i>.<sup><a href="#ref-39">39</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2772 class=n-a></a>1,119</td><td align=center colspan=1 rowspan=1><a name=d17791e2775 class=n-a></a>4.6</td><td align=center colspan=1 rowspan=1><a name=d17791e2778 class=n-a></a>3.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2781 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2785 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2788 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2791 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2794 class=n-a></a>-</td></tr><tr><a name=d17791e2797 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2798 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2800 class=n-a></a>Valente <i>et al</i>.<sup><a href="#ref-40">40</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2809 class=n-a></a>414</td><td align=center colspan=1 rowspan=1><a name=d17791e2812 class=n-a></a>7.2</td><td align=center colspan=1 rowspan=1><a name=d17791e2815 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2818 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2822 class=n-a></a>2.4</td><td align=center colspan=1 rowspan=1><a name=d17791e2825 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2828 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2831 class=n-a></a>-</td></tr><tr><a name=d17791e2834 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2835 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2837 class=n-a></a>Davidicius <i>et al</i>.<sup><a href="#ref-41">41</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2846 class=n-a></a>360</td><td align=center colspan=1 rowspan=1><a name=d17791e2849 class=n-a></a>19.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2852 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2855 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2859 class=n-a></a>4.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2862 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2865 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2868 class=n-a></a>-</td></tr><tr><a name=d17791e2871 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2872 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2874 class=n-a></a>Ternus <i>et al</i>.<sup><a href="#ref-42">42</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2883 class=n-a></a>682</td><td align=center colspan=1 rowspan=1><a name=d17791e2886 class=n-a></a>0.6</td><td align=center colspan=1 rowspan=1><a name=d17791e2889 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2892 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2896 class=n-a></a>1.3</td><td align=center colspan=1 rowspan=1><a name=d17791e2899 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2902 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2905 class=n-a></a>18.5</td></tr><tr><a name=d17791e2909 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2910 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2912 class=n-a></a>Schwartz <i>et al</i>.<sup><a href="#ref-43">43</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2921 class=n-a></a>50</td><td align=center colspan=1 rowspan=1><a name=d17791e2924 class=n-a></a>24.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2927 class=n-a></a>4.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2930 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2934 class=n-a></a>6.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2937 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2940 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2943 class=n-a></a>34.0</td></tr><tr><a name=d17791e2946 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2947 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2949 class=n-a></a>Mackenzie <i>et al</i>.<sup><a href="#ref-44">44</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2958 class=n-a></a>100</td><td align=center colspan=1 rowspan=1><a name=d17791e2961 class=n-a></a>2.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2964 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2967 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2971 class=n-a></a>25.0</td><td align=center colspan=1 rowspan=1><a name=d17791e2974 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2977 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e2980 class=n-a></a>40.0</td></tr><tr><a name=d17791e2983 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e2984 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e2986 class=n-a></a>Ozen <i>et al</i>.<sup><a href="#ref-45">45</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e2995 class=n-a></a>3,135</td><td align=center colspan=1 rowspan=1><a name=d17791e2998 class=n-a></a>1.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3001 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3004 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3008 class=n-a></a>12.3</td><td align=center colspan=1 rowspan=1><a name=d17791e3011 class=n-a></a>0.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3014 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3017 class=n-a></a>25.9</td></tr><tr><a name=d17791e3020 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3021 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3023 class=n-a></a>Arceo <i>et al</i>.<sup><a href="#ref-46">46</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3032 class=n-a></a>212</td><td align=center colspan=1 rowspan=1><a name=d17791e3035 class=n-a></a>2.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3038 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3041 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3045 class=n-a></a>5.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3048 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3051 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3054 class=n-a></a>45.0</td></tr><tr><a name=d17791e3057 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3058 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3060 class=n-a></a>Dick <i>et al</i>.<sup><a href="#ref-47">47</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3069 class=n-a></a>187</td><td align=center colspan=1 rowspan=1><a name=d17791e3072 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3075 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3078 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3082 class=n-a></a>2.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3085 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3088 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3091 class=n-a></a>7.2</td></tr><tr><a name=d17791e3094 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3095 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3097 class=n-a></a>Eltchaninoff <i>et al</i>.<sup><a href="#ref-48">48</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3106 class=n-a></a>240</td><td align=center colspan=1 rowspan=1><a name=d17791e3109 class=n-a></a>3.3</td><td align=center colspan=1 rowspan=1><a name=d17791e3112 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3115 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3119 class=n-a></a>12.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3122 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3125 class=n-a></a>0.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3128 class=n-a></a>24.0</td></tr><tr><a name=d17791e3132 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3133 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3135 class=n-a></a>Meisel <i>et al</i>.<sup><a href="#ref-49">49</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3144 class=n-a></a>161</td><td align=center colspan=1 rowspan=1><a name=d17791e3147 class=n-a></a>2.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3150 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3153 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3157 class=n-a></a>2.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3160 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3163 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3166 class=n-a></a>7.2</td></tr><tr><a name=d17791e3169 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3170 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3172 class=n-a></a>Pahuja <i>et al</i>.<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3184 class=n-a></a>86,796</td><td align=center colspan=1 rowspan=1><a name=d17791e3187 class=n-a></a>19.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3190 class=n-a></a>3.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3193 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3197 class=n-a></a>0.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3200 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3203 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3206 class=n-a></a>25.8</td></tr><tr><a name=d17791e3209 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3210 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3212 class=n-a></a><b>Weighted average</b></td><td colspan=1 rowspan=1><a name=d17791e3216 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17791e3218 class=n-a></a><b>12.9</b></td><td align=center colspan=1 rowspan=1><a name=d17791e3222 class=n-a></a><b>3.1</b></td><td align=center colspan=1 rowspan=1><a name=d17791e3226 class=n-a></a><b>17.2</b></td><td align=center colspan=1 rowspan=1><a name=d17791e3231 class=n-a></a><b>1.5</b></td><td align=center colspan=1 rowspan=1><a name=d17791e3235 class=n-a></a><b>0.6</b></td><td align=center colspan=1 rowspan=1><a name=d17791e3239 class=n-a></a><b>5.0</b></td><td align=center colspan=1 rowspan=1><a name=d17791e3243 class=n-a></a><b>24.2</b></td></tr><tr><a name=d17791e3248 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d17791e3250 class=n-a></a>Impella</th><th colspan=1 rowspan=1><a name=d17791e3253 class=n-a></a></th><th align=center colspan=1 rowspan=1><a name=d17791e3255 class=n-a></a>n</th><th align=center colspan=1 rowspan=1><a name=d17791e3258 class=n-a></a>Bleeding (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e3261 class=n-a></a>Stroke (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e3265 class=n-a></a>AKI (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e3268 class=n-a></a>Limb<br class=br>ischemia (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e3273 class=n-a></a>Hemolysis (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e3276 class=n-a></a>Sepsis (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e3279 class=n-a></a>Death (%)</th></tr><tr><a name=d17791e3282 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3283 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3285 class=n-a></a>Tehrani <i>et al</i>.<sup><a href="#ref-11">11</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3294 class=n-a></a>67</td><td align=center colspan=1 rowspan=1><a name=d17791e3297 class=n-a></a>4.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3300 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3303 class=n-a></a>25.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3307 class=n-a></a>4.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3310 class=n-a></a>10.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3313 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3316 class=n-a></a>-</td></tr><tr><a name=d17791e3319 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3320 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3322 class=n-a></a>Annamalai <i>et al</i>.<sup><a href="#ref-50">50</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3331 class=n-a></a>34</td><td align=center colspan=1 rowspan=1><a name=d17791e3334 class=n-a></a>20.6</td><td align=center colspan=1 rowspan=1><a name=d17791e3337 class=n-a></a>5.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3340 class=n-a></a>47.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3344 class=n-a></a>8.8</td><td align=center colspan=1 rowspan=1><a name=d17791e3347 class=n-a></a>11.8</td><td align=center colspan=1 rowspan=1><a name=d17791e3350 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3353 class=n-a></a>38.0</td></tr><tr><a name=d17791e3357 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3358 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3360 class=n-a></a>Alushi <i>et al</i>.<sup><a href="#ref-33">33</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3369 class=n-a></a>62</td><td align=center colspan=1 rowspan=1><a name=d17791e3372 class=n-a></a>14.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3375 class=n-a></a>1.6</td><td align=center colspan=1 rowspan=1><a name=d17791e3378 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3382 class=n-a></a>8.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3385 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3388 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3391 class=n-a></a>67.0</td></tr><tr><a name=d17791e3394 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3395 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3397 class=n-a></a>O’Neill <i>et al</i>.<sup><a href="#ref-51">51</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3406 class=n-a></a>154</td><td align=center colspan=1 rowspan=1><a name=d17791e3409 class=n-a></a>20.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3412 class=n-a></a>1.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3415 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3419 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3422 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3425 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3428 class=n-a></a>-</td></tr><tr><a name=d17791e3431 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3432 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3434 class=n-a></a>Jensen <i>et al</i>.<sup><a href="#ref-52">52</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3443 class=n-a></a>109</td><td align=center colspan=1 rowspan=1><a name=d17791e3446 class=n-a></a>59.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3449 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3452 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3456 class=n-a></a>10.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3459 class=n-a></a>11.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3462 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3465 class=n-a></a>-</td></tr><tr><a name=d17791e3468 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3469 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3471 class=n-a></a>Karatolios <i>et al</i>.<sup><a href="#ref-53">53</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3480 class=n-a></a>27</td><td align=center colspan=1 rowspan=1><a name=d17791e3483 class=n-a></a>62.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3486 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3489 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3493 class=n-a></a>3.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3496 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3499 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3502 class=n-a></a>-</td></tr><tr><a name=d17791e3505 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3506 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3508 class=n-a></a>Karami <i>et al</i>.<sup><a href="#ref-54">54</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3517 class=n-a></a>90</td><td align=center colspan=1 rowspan=1><a name=d17791e3520 class=n-a></a>23.3</td><td align=center colspan=1 rowspan=1><a name=d17791e3523 class=n-a></a>4.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3526 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3530 class=n-a></a>2.2</td><td align=center colspan=1 rowspan=1><a name=d17791e3533 class=n-a></a>6.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3536 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3539 class=n-a></a>52.2</td></tr><tr><a name=d17791e3542 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3543 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3545 class=n-a></a>Pieri <i>et al</i>.<sup><a href="#ref-34">34</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3554 class=n-a></a>28</td><td align=center colspan=1 rowspan=1><a name=d17791e3557 class=n-a></a>35.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3560 class=n-a></a>7.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3563 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3567 class=n-a></a>18.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3570 class=n-a></a>32.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3573 class=n-a></a>29.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3576 class=n-a></a>21.0</td></tr><tr><a name=d17791e3580 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3581 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3583 class=n-a></a>Basir <i>et al</i>.<sup><a href="#ref-55">55</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3592 class=n-a></a>171</td><td align=center colspan=1 rowspan=1><a name=d17791e3595 class=n-a></a>7.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3598 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3601 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3605 class=n-a></a>4.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3608 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3611 class=n-a></a>28.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3614 class=n-a></a>-</td></tr><tr><a name=d17791e3617 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3618 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3620 class=n-a></a>Ternus <i>et al</i>.<sup><a href="#ref-42">42</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3629 class=n-a></a>96</td><td align=center colspan=1 rowspan=1><a name=d17791e3632 class=n-a></a>5.2</td><td align=center colspan=1 rowspan=1><a name=d17791e3635 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3638 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3642 class=n-a></a>2.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3645 class=n-a></a>1.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3648 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3651 class=n-a></a>30.2</td></tr><tr><a name=d17791e3654 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3655 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3657 class=n-a></a>Kaki <i>et al</i>.<sup><a href="#ref-56">56</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3666 class=n-a></a>17</td><td align=center colspan=1 rowspan=1><a name=d17791e3669 class=n-a></a>5.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3672 class=n-a></a>5.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3675 class=n-a></a>41.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3679 class=n-a></a>5.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3682 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3685 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3688 class=n-a></a>70.6</td></tr><tr><a name=d17791e3691 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3692 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3694 class=n-a></a>Lauten <i>et al</i>.<sup><a href="#ref-57">57</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3703 class=n-a></a>120</td><td align=center colspan=1 rowspan=1><a name=d17791e3706 class=n-a></a>28.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3709 class=n-a></a>1.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3712 class=n-a></a>31.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3716 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3719 class=n-a></a>7.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3722 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3725 class=n-a></a>64.2</td></tr><tr><a name=d17791e3728 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3729 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3731 class=n-a></a>Ouweneel <i>et al</i>.<sup><a href="#ref-58">58</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3740 class=n-a></a>112</td><td align=center colspan=1 rowspan=1><a name=d17791e3743 class=n-a></a>25.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3746 class=n-a></a>3.6</td><td align=center colspan=1 rowspan=1><a name=d17791e3749 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3753 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3756 class=n-a></a>7.1</td><td align=center colspan=1 rowspan=1><a name=d17791e3759 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3762 class=n-a></a>65.0</td></tr><tr><a name=d17791e3765 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3766 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3768 class=n-a></a>Badiye <i>et al</i>.<sup><a href="#ref-59">59</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3777 class=n-a></a>40</td><td align=center colspan=1 rowspan=1><a name=d17791e3780 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3783 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3786 class=n-a></a>42.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3790 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3793 class=n-a></a>62.5</td><td align=center colspan=1 rowspan=1><a name=d17791e3796 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3799 class=n-a></a>32.5</td></tr><tr><a name=d17791e3803 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3804 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3806 class=n-a></a>Esposito <i>et al</i>.<sup><a href="#ref-60">60</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3815 class=n-a></a>23</td><td align=center colspan=1 rowspan=1><a name=d17791e3818 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3821 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3824 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3828 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3831 class=n-a></a>30.4</td><td align=center colspan=1 rowspan=1><a name=d17791e3834 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3837 class=n-a></a>57.0</td></tr><tr><a name=d17791e3840 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3841 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3843 class=n-a></a>Schwartz <i>et al</i>.<sup><a href="#ref-43">43</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3852 class=n-a></a>7</td><td align=center colspan=1 rowspan=1><a name=d17791e3855 class=n-a></a>57.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3858 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3861 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3865 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3868 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3871 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3874 class=n-a></a>14.0</td></tr><tr><a name=d17791e3877 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3878 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3880 class=n-a></a>Garan <i>et al</i>.<sup><a href="#ref-12">12</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3889 class=n-a></a>31</td><td align=center colspan=1 rowspan=1><a name=d17791e3892 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3895 class=n-a></a>12.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3898 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3902 class=n-a></a>12.9</td><td align=center colspan=1 rowspan=1><a name=d17791e3905 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3908 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3911 class=n-a></a>45.2</td></tr><tr><a name=d17791e3914 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3915 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3917 class=n-a></a>Lamarche <i>et al</i>.<sup><a href="#ref-61">61</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e3926 class=n-a></a>29</td><td align=center colspan=1 rowspan=1><a name=d17791e3929 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3932 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3935 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3939 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e3942 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3945 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3948 class=n-a></a>38.0</td></tr><tr><a name=d17791e3951 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3952 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3954 class=n-a></a>Anderson <i>et al</i>.<sup><a href="#ref-62">62</a></sup> (RP)</td><td align=center colspan=1 rowspan=1><a name=d17791e3964 class=n-a></a>60</td><td align=center colspan=1 rowspan=1><a name=d17791e3967 class=n-a></a>48.3</td><td align=center colspan=1 rowspan=1><a name=d17791e3970 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3973 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3977 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3980 class=n-a></a>21.7</td><td align=center colspan=1 rowspan=1><a name=d17791e3983 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e3986 class=n-a></a>26.7</td></tr><tr><a name=d17791e3989 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e3990 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e3992 class=n-a></a>Pahuja <i>et al</i>.<sup><a href="#ref-22">22</a></sup>,23</td><td align=center colspan=1 rowspan=1><a name=d17791e4002 class=n-a></a>2,079</td><td align=center colspan=1 rowspan=1><a name=d17791e4005 class=n-a></a>29.9</td><td align=center colspan=1 rowspan=1><a name=d17791e4008 class=n-a></a>5.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4011 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4015 class=n-a></a>3.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4018 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4021 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4024 class=n-a></a>41.0</td></tr><tr><a name=d17791e4028 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4029 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4031 class=n-a></a><b>Weighted average</b></td><td colspan=1 rowspan=1><a name=d17791e4035 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17791e4037 class=n-a></a><b>27.7</b></td><td align=center colspan=1 rowspan=1><a name=d17791e4041 class=n-a></a><b>4.9</b></td><td align=center colspan=1 rowspan=1><a name=d17791e4045 class=n-a></a><b>34.1</b></td><td align=center colspan=1 rowspan=1><a name=d17791e4050 class=n-a></a><b>4.2</b></td><td align=center colspan=1 rowspan=1><a name=d17791e4054 class=n-a></a><b>13.1</b></td><td align=center colspan=1 rowspan=1><a name=d17791e4058 class=n-a></a><b>28.1</b></td><td align=center colspan=1 rowspan=1><a name=d17791e4062 class=n-a></a><b>43.1</b></td></tr><tr><a name=d17791e4067 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d17791e4069 class=n-a></a>ECMO</th><th align=left colspan=1 rowspan=1><a name=d17791e4072 class=n-a></a></th><th align=center colspan=1 rowspan=1><a name=d17791e4074 class=n-a></a>n</th><th align=center colspan=1 rowspan=1><a name=d17791e4077 class=n-a></a>Bleeding (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e4080 class=n-a></a>Stroke (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e4084 class=n-a></a>AKI (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e4087 class=n-a></a>Limb<br class=br>ischemia (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e4092 class=n-a></a>Hemolysis (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e4095 class=n-a></a>Sepsis (%)</th><th align=center colspan=1 rowspan=1><a name=d17791e4098 class=n-a></a>Death (%)</th></tr><tr><a name=d17791e4101 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4102 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4104 class=n-a></a>Tehrani <i>et al</i>.<sup><a href="#ref-11">11</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4113 class=n-a></a>31</td><td align=center colspan=1 rowspan=1><a name=d17791e4116 class=n-a></a>16.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4119 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4122 class=n-a></a>51.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4126 class=n-a></a>19.4</td><td align=center colspan=1 rowspan=1><a name=d17791e4129 class=n-a></a>38.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4132 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4135 class=n-a></a>-</td></tr><tr><a name=d17791e4138 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4139 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4141 class=n-a></a>Karami <i>et al</i>.<sup><a href="#ref-54">54</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4150 class=n-a></a>38</td><td align=center colspan=1 rowspan=1><a name=d17791e4153 class=n-a></a>31.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4156 class=n-a></a>10.5</td><td align=center colspan=1 rowspan=1><a name=d17791e4159 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4163 class=n-a></a>5.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4166 class=n-a></a>0.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4169 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4172 class=n-a></a>47.4</td></tr><tr><a name=d17791e4175 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4176 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4178 class=n-a></a>Chamogeorgakis <i>et al</i>.<sup><a href="#ref-63">63</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4187 class=n-a></a>61</td><td align=center colspan=1 rowspan=1><a name=d17791e4190 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4193 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4196 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4200 class=n-a></a>13.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4203 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4206 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4209 class=n-a></a>50.8</td></tr><tr><a name=d17791e4212 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4213 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4215 class=n-a></a>Hoefer <i>et al</i>.<sup><a href="#ref-64">64</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4224 class=n-a></a>131</td><td align=center colspan=1 rowspan=1><a name=d17791e4227 class=n-a></a>11.5</td><td align=center colspan=1 rowspan=1><a name=d17791e4230 class=n-a></a>2.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4233 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4237 class=n-a></a>1.5</td><td align=center colspan=1 rowspan=1><a name=d17791e4240 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4243 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4246 class=n-a></a>-</td></tr><tr><a name=d17791e4250 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4251 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4253 class=n-a></a>Koerner <i>et al</i>.<sup><a href="#ref-65">65</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4262 class=n-a></a>184</td><td align=center colspan=1 rowspan=1><a name=d17791e4265 class=n-a></a>22.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4268 class=n-a></a>4.9</td><td align=center colspan=1 rowspan=1><a name=d17791e4271 class=n-a></a>16.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4275 class=n-a></a>4.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4278 class=n-a></a>9.2</td><td align=center colspan=1 rowspan=1><a name=d17791e4281 class=n-a></a>18.5</td><td align=center colspan=1 rowspan=1><a name=d17791e4284 class=n-a></a>61.0</td></tr><tr><a name=d17791e4287 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4288 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4290 class=n-a></a>Lorusso <i>et al</i>.<sup><a href="#ref-66">66</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4299 class=n-a></a>4,522</td><td align=center colspan=1 rowspan=1><a name=d17791e4302 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4305 class=n-a></a>5.4</td><td align=center colspan=1 rowspan=1><a name=d17791e4308 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4312 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4315 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4318 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4321 class=n-a></a>-</td></tr><tr><a name=d17791e4324 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4325 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4327 class=n-a></a>Garan <i>et al</i>.<sup><a href="#ref-12">12</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4336 class=n-a></a>20</td><td align=center colspan=1 rowspan=1><a name=d17791e4339 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4342 class=n-a></a>25.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4345 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4349 class=n-a></a>10.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4352 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4355 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4358 class=n-a></a>45.0</td></tr><tr><a name=d17791e4361 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4362 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4364 class=n-a></a>Kolla <i>et al</i>.<sup><a href="#ref-67">67</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4373 class=n-a></a>27</td><td align=center colspan=1 rowspan=1><a name=d17791e4376 class=n-a></a>16.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4379 class=n-a></a>7.4</td><td align=center colspan=1 rowspan=1><a name=d17791e4382 class=n-a></a>56.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4386 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4389 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4392 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4395 class=n-a></a>70.0</td></tr><tr><a name=d17791e4398 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4399 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4401 class=n-a></a>Gulkarov <i>et al</i>.<sup><a href="#ref-68">68</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4410 class=n-a></a>71</td><td align=center colspan=1 rowspan=1><a name=d17791e4413 class=n-a></a>4.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4416 class=n-a></a>14.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4419 class=n-a></a>45.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4423 class=n-a></a>19.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4426 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4429 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4432 class=n-a></a>53.5</td></tr><tr><a name=d17791e4435 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4436 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4438 class=n-a></a>Yau <i>et al</i>.<sup><a href="#ref-69">69</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4447 class=n-a></a>154</td><td align=center colspan=1 rowspan=1><a name=d17791e4450 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4453 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4456 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4460 class=n-a></a>22.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4463 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4466 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4469 class=n-a></a>59.7</td></tr><tr><a name=d17791e4473 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4474 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4476 class=n-a></a>Avalli <i>et al</i>.<sup><a href="#ref-70">70</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4485 class=n-a></a>100</td><td align=center colspan=1 rowspan=1><a name=d17791e4488 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4491 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4494 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4498 class=n-a></a>35.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4501 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4504 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4507 class=n-a></a>72.0</td></tr><tr><a name=d17791e4510 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4511 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4513 class=n-a></a>Wong <i>et al</i>.<sup><a href="#ref-71">71</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4522 class=n-a></a>193</td><td align=center colspan=1 rowspan=1><a name=d17791e4525 class=n-a></a>18</td><td align=center colspan=1 rowspan=1><a name=d17791e4528 class=n-a></a>9.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4531 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4535 class=n-a></a>11.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4538 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4541 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4544 class=n-a></a>61.0</td></tr><tr><a name=d17791e4547 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4548 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4550 class=n-a></a>Ranney <i>et al</i>.<sup><a href="#ref-72">72</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4559 class=n-a></a>80</td><td align=center colspan=1 rowspan=1><a name=d17791e4562 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4565 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4568 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4572 class=n-a></a>21.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4575 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4578 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4581 class=n-a></a>60.0</td></tr><tr><a name=d17791e4584 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4585 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4587 class=n-a></a>Foley <i>et al</i>.<sup><a href="#ref-73">73</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4596 class=n-a></a>43</td><td align=center colspan=1 rowspan=1><a name=d17791e4599 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4602 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4605 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4609 class=n-a></a>16.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4612 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4615 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4618 class=n-a></a>79.0</td></tr><tr><a name=d17791e4621 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4622 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4624 class=n-a></a>Lamb <i>et al</i>.<sup><a href="#ref-74">74</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4633 class=n-a></a>91</td><td align=center colspan=1 rowspan=1><a name=d17791e4636 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4639 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4642 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4646 class=n-a></a>13.2</td><td align=center colspan=1 rowspan=1><a name=d17791e4649 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4652 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4655 class=n-a></a>58.0</td></tr><tr><a name=d17791e4658 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4659 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4661 class=n-a></a>Belle <i>et al</i>.<sup><a href="#ref-75">75</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4670 class=n-a></a>51</td><td align=center colspan=1 rowspan=1><a name=d17791e4673 class=n-a></a>39.2</td><td align=center colspan=1 rowspan=1><a name=d17791e4676 class=n-a></a>3.9</td><td align=center colspan=1 rowspan=1><a name=d17791e4679 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4683 class=n-a></a>17.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4686 class=n-a></a>13.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4689 class=n-a></a>13.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4692 class=n-a></a>72.5</td></tr><tr><a name=d17791e4696 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4697 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4699 class=n-a></a>Bermudez <i>et al</i>.<sup><a href="#ref-76">76</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4708 class=n-a></a>42</td><td colspan=1 rowspan=1><a name=d17791e4711 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17791e4713 class=n-a></a>11.9</td><td align=center colspan=1 rowspan=1><a name=d17791e4716 class=n-a></a>40.5</td><td align=center colspan=1 rowspan=1><a name=d17791e4720 class=n-a></a>14.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4723 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4726 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4729 class=n-a></a>62.0</td></tr><tr><a name=d17791e4732 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4733 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4735 class=n-a></a>Kim <i>et al</i>.<sup><a href="#ref-77">77</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4744 class=n-a></a>27</td><td align=center colspan=1 rowspan=1><a name=d17791e4747 class=n-a></a>14.2</td><td align=center colspan=1 rowspan=1><a name=d17791e4750 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4753 class=n-a></a>37.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4757 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4760 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4763 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4766 class=n-a></a>41.7</td></tr><tr><a name=d17791e4769 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4770 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4772 class=n-a></a>Esper <i>et al</i>.<sup><a href="#ref-78">78</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4781 class=n-a></a>18</td><td align=center colspan=1 rowspan=1><a name=d17791e4784 class=n-a></a>94.4</td><td align=center colspan=1 rowspan=1><a name=d17791e4787 class=n-a></a>5.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4790 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4794 class=n-a></a>22.2</td><td align=center colspan=1 rowspan=1><a name=d17791e4797 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4800 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4803 class=n-a></a>33.0</td></tr><tr><a name=d17791e4806 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4807 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4809 class=n-a></a>Loforte <i>et al</i>.<sup><a href="#ref-79">79</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4818 class=n-a></a>73</td><td align=center colspan=1 rowspan=1><a name=d17791e4821 class=n-a></a>50.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4824 class=n-a></a>15.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4827 class=n-a></a>52.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4831 class=n-a></a>54.8</td><td align=center colspan=1 rowspan=1><a name=d17791e4834 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4837 class=n-a></a>15.1</td><td align=center colspan=1 rowspan=1><a name=d17791e4840 class=n-a></a>54.8</td></tr><tr><a name=d17791e4843 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4844 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4846 class=n-a></a>Moraca <i>et al</i>.<sup><a href="#ref-80">80</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4855 class=n-a></a>26</td><td align=center colspan=1 rowspan=1><a name=d17791e4858 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4861 class=n-a></a>7.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4864 class=n-a></a>34.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4868 class=n-a></a>7.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4871 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4874 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4877 class=n-a></a>35.0</td></tr><tr><a name=d17791e4880 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4881 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4883 class=n-a></a>Pagani <i>et al</i>.<sup><a href="#ref-81">81</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4892 class=n-a></a>33</td><td align=center colspan=1 rowspan=1><a name=d17791e4895 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4898 class=n-a></a>0.9</td><td align=center colspan=1 rowspan=1><a name=d17791e4901 class=n-a></a>30.3</td><td align=center colspan=1 rowspan=1><a name=d17791e4905 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4908 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4911 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4914 class=n-a></a>64.0</td></tr><tr><a name=d17791e4918 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4919 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4921 class=n-a></a>Wu <i>et al</i>.<sup><a href="#ref-82">82</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4930 class=n-a></a>60</td><td align=center colspan=1 rowspan=1><a name=d17791e4933 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4936 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4939 class=n-a></a>31.7</td><td align=center colspan=1 rowspan=1><a name=d17791e4943 class=n-a></a>10.0</td><td align=center colspan=1 rowspan=1><a name=d17791e4946 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4949 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4952 class=n-a></a>47.0</td></tr><tr><a name=d17791e4955 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4956 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4958 class=n-a></a>Formica <i>et al</i>.<sup><a href="#ref-83">83</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e4967 class=n-a></a>42</td><td align=center colspan=1 rowspan=1><a name=d17791e4970 class=n-a></a>54.8</td><td align=center colspan=1 rowspan=1><a name=d17791e4973 class=n-a></a>26.2</td><td align=center colspan=1 rowspan=1><a name=d17791e4976 class=n-a></a>47.6</td><td align=center colspan=1 rowspan=1><a name=d17791e4980 class=n-a></a>21.4</td><td align=center colspan=1 rowspan=1><a name=d17791e4983 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4986 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e4989 class=n-a></a>61.9</td></tr><tr><a name=d17791e4992 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e4993 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e4995 class=n-a></a>Lamarche <i>et al</i>.<sup><a href="#ref-61">61</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e5004 class=n-a></a>32</td><td align=center colspan=1 rowspan=1><a name=d17791e5007 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5010 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5013 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5017 class=n-a></a>15.6</td><td align=center colspan=1 rowspan=1><a name=d17791e5020 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5023 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5026 class=n-a></a>44.0</td></tr><tr><a name=d17791e5029 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e5030 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e5032 class=n-a></a>Batra <i>et al</i>.<sup><a href="#ref-84">84</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e5041 class=n-a></a>1,286</td><td align=center colspan=1 rowspan=1><a name=d17791e5044 class=n-a></a>32.3</td><td align=center colspan=1 rowspan=1><a name=d17791e5047 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5050 class=n-a></a>21.1</td><td align=center colspan=1 rowspan=1><a name=d17791e5054 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5057 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5060 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5063 class=n-a></a>54.1</td></tr><tr><a name=d17791e5066 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e5067 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e5069 class=n-a></a>Vallabhajosyula <i>et al</i>.<sup><a href="#ref-85">85</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e5078 class=n-a></a>4,608</td><td align=center colspan=1 rowspan=1><a name=d17791e5081 class=n-a></a>25.3</td><td align=center colspan=1 rowspan=1><a name=d17791e5084 class=n-a></a>10.8</td><td align=center colspan=1 rowspan=1><a name=d17791e5087 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5091 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5094 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5097 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5100 class=n-a></a>57.7</td></tr><tr><a name=d17791e5103 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e5104 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e5106 class=n-a></a>Pahuja <i>et al</i>.<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup></td><td align=center colspan=1 rowspan=1><a name=d17791e5118 class=n-a></a>444</td><td align=center colspan=1 rowspan=1><a name=d17791e5121 class=n-a></a>54.2</td><td align=center colspan=1 rowspan=1><a name=d17791e5124 class=n-a></a>9.7</td><td align=center colspan=1 rowspan=1><a name=d17791e5127 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5131 class=n-a></a>7.7</td><td align=center colspan=1 rowspan=1><a name=d17791e5134 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5137 class=n-a></a>-</td><td align=center colspan=1 rowspan=1><a name=d17791e5140 class=n-a></a>55.9</td></tr><tr><a name=d17791e5144 class=n-a></a><td colspan=1 rowspan=1><a name=d17791e5145 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d17791e5147 class=n-a></a><b>Weighted average</b></td><td colspan=1 rowspan=1><a name=d17791e5151 class=n-a></a></td><td align=center colspan=1 rowspan=1><a name=d17791e5153 class=n-a></a><b>28.2</b></td><td align=center colspan=1 rowspan=1><a name=d17791e5157 class=n-a></a><b>8.2</b></td><td align=center colspan=1 rowspan=1><a name=d17791e5161 class=n-a></a><b>25.6</b></td><td align=center colspan=1 rowspan=1><a name=d17791e5166 class=n-a></a><b>14.3</b></td><td align=center colspan=1 rowspan=1><a name=d17791e5170 class=n-a></a><b>11.8</b></td><td align=center colspan=1 rowspan=1><a name=d17791e5174 class=n-a></a><b>16.9</b></td><td align=center colspan=1 rowspan=1><a name=d17791e5178 class=n-a></a><b>57.2</b></td></tr></tbody></table></div><p class="" id=d17791e5186>A final class of studies which have been used to compare relative complication rates between devices are comparative observational analyses, which attempt to adjust for the significant baseline differences observed in cases series by attempting to match patients across available clinical variables. Three such studies have recently spurred substantial debate about complications related to Impella use. Schrage <i>et al.</i> performed a matched analysis comparing 237 CS patients treated with Impella in 13 European centers to 237 matched patients taken from both arms (IABP and medical therapy) of the IABP-SHOCK II trial<sup><a href="#ref-24">24</a></sup>. Amin <i>et al.</i> identified patients undergoing PCI with MCS (linked by same-day billing data), some of whom had CS, and performed a propensity matched analysis comparing those managed with Impella with those managed by IABP<sup><a href="#ref-25">25</a></sup>. Finally, Dhruva <i>et al.</i> linked two registries to identify AMICS patients managed with Impella or IABP, matched for 75 baseline variables (though, notably, lactate and hemodynamic parameters were not available for matching)<sup><a href="#ref-26">26</a></sup>. Each study reported a higher rate of complications associated with Impella compared to IABP. Even more striking, the Amin and Dhruva studies reported a significantly higher rate of in-hospital mortality in patients treated with Impella, raising the concern that the additional complications associated with Impella may translate to higher mortality. While these analyses corroborate the trends observed in observational case series as summarized in <a href="#T2">Table 2</a>, their salience ultimately depends on the validity of their respective mortality comparisons. As previously discussed, it is relatively obvious why larger sheath sizes would cause higher rates of bleeding and limb ischemia; whether morbidity from these complications outweighs the benefits afforded by greater hemodynamic support in patients with severe shock for whom an IABP would be inadequate remains unanswered. We argue that this question can be properly answered only through trials comparing CS patients randomized to different devices and powered for hard clinical endpoints. No amount of propensity matching—particularly when the most well-validated prognostic variables in CS such as central venous pressure, lactate, and cardiac power output are missing—can account for the vast baseline differences between real-world patients being managed with these different devices. The ongoing DanGer shock trial and other trials may shed light on these critical questions<sup><a href="#ref-27">27</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17791e5221>Moving forward without data</h2><p class="" id=d17791e5224>In the absence of high-quality randomized data clarifying the net risks and benefits of MCS platforms in CS, practitioners still need to move forward and manage individual patients with CS. Recognizing that there are likely higher rates of at least some complications (bleeding, limb ischemia, and hemolysis) with Impella and VA-ECMO compared to IABP, shock practitioners should redouble their efforts to adhere to the following best practices.</p><div class=section><a name=d17791e5227 class=n-a></a><h3 class=section-title>Rapid, coordinated multi-specialty evaluation of patients with suspected cardiogenic shock</h3><p class="" id=d17791e5232>Institutions should design structured responses (such as the ‘Shock Team’) to ensure that patients with suspected CS are rapidly identified and evaluated by qualified practitioners so that necessary resources can be urgently made available and evaluations begun regarding the likelihood of recovery or candidacy for durable MCS or transplant. Depending on the suspected inciting insult and local staffing patterns, the shock team might include interventional cardiologists, heart failure specialists, (cardiac) intensivists, and cardiac/vascular surgeons along with perfusionists and critical care nurses. Some have suggested that the cath lab be used as a default staging ground where right heart catheterization, coronary angiography, and fluoroscopic MCS insertion can all be rapidly performed<sup><a href="#ref-11">11</a></sup>.</p></div><div class=section><a name=d17791e5240 class=n-a></a><h3 class=section-title>Comprehensive invasive hemodynamic assessment to guide device selection and management</h3><p class="" id=d17791e5245>Critical to maximizing the risks and benefits of MCS is the use of objective hemodynamic assessment using pulmonary artery catheters (PACs) to guide device selection. Just as it is important to identify the crashing patient with severe biventricular congestion who is unlikely to stabilize with IABP alone, it is equally important to identify the STEMI patient with isolated left ventricular failure well-suited for left-sided Impella, sparing them the additional complications of a more invasive device like VA-ECMO. We and others have proposed algorithms for device selection based on the ventricular congestive profile and validated indices of right ventricular function such as pulmonary artery pulsatility index (PAPi), along with the presence of concurrent respiratory failure<sup><a href="#ref-10">10</a>,<a href="#ref-12">12</a></sup>. Recent data suggest that algorithms incorporating hemodynamically guided decision-making may lead to improved survival in AMICS (<a href="#f1">Figure 1</a>), though observational studies directly examining associations between PAC use and clinical outcomes in CS have yielded mixed results<sup><a href="#ref-11">11</a>,<a href="#ref-28">28</a>–<a href="#ref-31">31</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/28160/8321ef66-c8a5-4cf4-9016-85251ce53002_figure1.gif"><img alt="8321ef66-c8a5-4cf4-9016-85251ce53002_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/28160/8321ef66-c8a5-4cf4-9016-85251ce53002_figure1.gif"></a><div class=caption><h3>Figure 1. Survival and studies in acute myocardial infarction cardiogenic shock.</h3><p id=d17791e5278>Two recent prospective registries employing a hemodynamically driven treatment algorithm have reported higher survival rates compared to several recent randomized controlled trials (RCTs) that failed to use hemodynamic data to guide device selection or device management.</p></div></div></div><div class=section><a name=d17791e5286 class=n-a></a><h3 class=section-title>Fastidious prevention of and monitoring for the development of complications</h3><p class="" id=d17791e5291>Many complications can be avoided or their impact minimized if recognized and managed promptly. For example, a careful vascular assessment should be performed daily to monitor for signs of limb ischemia, which may require intervention such as external bypass or addition of a distal perfusion catheter. Similarly, markers of hemolysis should be continually tracked to assess the need for device repositioning and thorough neurologic exams performed to identify signs of stroke, which can be particularly difficult to recognize in unconscious patients. In ECMO patients, right upper extremity oxygen saturation and pulmonary capillary wedge pressure should be continuously monitored for the development of Harlequin syndrome and left ventricular distension, which may require optimization of ventilator settings, upgrade to a VAV-ECMO configuration, or addition of a left ventricular vent<sup><a href="#ref-9">9</a></sup>. We would refer readers to a comprehensive review by Subramaniam and colleagues for further discussion of risk factors and strategies to reduce complications from acute MCS devices<sup><a href="#ref-14">14</a></sup>.</p></div><div class=section><a name=d17791e5304 class=n-a></a><h3 class=section-title>Continuous re-assessment to guide device weaning or escalation</h3><p class="" id=d17791e5309>Aside from complications occurring at the time of device insertion or removal, most occur as a function of time on support. Multimodal data (labs, hemodynamic parameters, echocardiography) should be continuously re-integrated to assess for the possibility of device weaning or the need for escalation. Specific thresholds (cardiac power output &lt;0.6, PAPi &lt;0.9) have been proposed to guide consideration of escalation or addition of right-sided support, though specific device algorithms will depend on local availability<sup><a href="#ref-30">30</a></sup>.</p></div><div class=section><a name=d17791e5317 class=n-a></a><h3 class=section-title>Implementation of best practices for device removal</h3><p class="" id=d17791e5322>Large bore access devices above 17Fr are commonly referred to vascular surgery for removal. However, with emerging techniques, devices ranging from 12Fr to 17Fr may be removed with percutaneous closure approaches. The Perclose device (Abbott Inc) can be used at the time of device implantation (pre-closure approach) or at the time of device removal (post-closure approach) to rapidly achieve hemostasis. The Manta closure device (Teleflex Inc) has recently been introduced and may represent another approach for percutaneous vascular hemostasis. The introduction of the Impella CP with a side-arm access port allows for device removal and post-closure, thereby mitigating vascular complication risk at the time of device removal<sup><a href="#ref-32">32</a></sup>. Each operator must develop these technical skills to improve outcomes.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17791e5333>Conclusion</h2><p class="" id=d17791e5336>CS is a complex clinical syndrome that remains a major cause of global mortality and morbidity. MCS device utilization is growing for cardiogenic shock, though each MCS platform is associated with risks. High-quality randomized controlled trials evaluating the use of MCS devices for CS are currently lacking but are in development. Recent reports utilizing administrative datasets and retrospective registries are of limited value other than to raise awareness that randomized controlled trials are needed to improve outcomes for patients. Progress in the field will be made only when high-quality randomized trials are conducted in defined populations, powered for all-cause mortality. The decision to place an advanced device should be made by an experienced shock practitioner or team using the most complete information possible. In the meantime, clinicians should educate themselves about hemodynamically driven decision-making algorithms and best practices to reduce complications associated with each MCS platform.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d17791e5343 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class=faculty-opinion-icon></span><span class="prime-red big">Faculty Opinions recommended</span></span><h2 class=main-title id=d18369>References</h2><div class="section ref-list"><a name=d17791e5343 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d17791e5350 class=n-a></a>van Diepen S, Katz JN, Albert NM, <i> et al.</i>: Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. <i>Circulation.</i> 2017; <b>136</b>(6): e232–e268. <a target=xrefwindow id=d17791e5361 href="http://www.ncbi.nlm.nih.gov/pubmed/28923988">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5364 href="https://doi.org/10.1161/CIR.0000000000000525">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727162766"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5373 class=n-a></a>Basir MB, Schreiber TL, Grines CL, <i> et al.</i>: Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. <i>Am J Cardiol.</i> 2017; <b>119</b>(6): 845–51. <a target=xrefwindow id=d17791e5384 href="http://www.ncbi.nlm.nih.gov/pubmed/28040188">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5387 href="https://doi.org/10.1016/j.amjcard.2016.11.037">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727162766">Faculty Opinions Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d17791e5400 class=n-a></a>Parissis H, Graham V, Lampridis S, <i> et al.</i>: IABP: History-evolution-pathophysiology-indications: what we need to know. <i>J Cardiothorac Surg.</i> 2016; <b>11</b>(1): 122. <a target=xrefwindow id=d17791e5411 href="http://www.ncbi.nlm.nih.gov/pubmed/27487772">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5414 href="https://doi.org/10.1186/s13019-016-0513-0">Publisher Full Text </a> | <a target=xrefwindow id=d17791e5418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4972967">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/717954110"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5427 class=n-a></a>Thiele H, Zeymer U, Neumann FJ, <i> et al.</i>: Intraaortic balloon support for myocardial infarction with cardiogenic shock. <i>N Engl J Med.</i> 2012; <b>367</b>(14): 1287–96. <a target=xrefwindow id=d17791e5438 href="http://www.ncbi.nlm.nih.gov/pubmed/22920912">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5441 href="https://doi.org/10.1056/NEJMoa1208410">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/717954110">Faculty Opinions Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/718102227"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5454 class=n-a></a>Thiele H, Zeymer U, Neumann FJ, <i> et al.</i>: Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial. <i>Lancet.</i> 2013; <b>382</b>(9905): 1638–45. <a target=xrefwindow id=d17791e5465 href="http://www.ncbi.nlm.nih.gov/pubmed/24011548">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5468 href="https://doi.org/10.1016/S0140-6736(13)61783-3">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/718102227">Faculty Opinions Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734701417"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5482 class=n-a></a>Thiele H, Zeymer U, Thelemann N, <i> et al.</i>: Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial. <i>Circulation.</i> 2018. <a target=xrefwindow id=d17791e5490 href="http://www.ncbi.nlm.nih.gov/pubmed/30586721">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5493 href="https://doi.org/10.1161/CIRCULATIONAHA.118.038201">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734701417">Faculty Opinions Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d17791e5506 class=n-a></a>Briceno N, Kapur NK, Perera D: Percutaneous mechanical circulatory support: Current concepts and future directions. <i>Heart.</i> 2016; <b>102</b>(18): 1494–507. <a target=xrefwindow id=d17791e5514 href="http://www.ncbi.nlm.nih.gov/pubmed/27503999">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5517 href="https://doi.org/10.1136/heartjnl-2015-308562">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d17791e5526 class=n-a></a>Kapur NK, Esposito ML, Bader Y, <i> et al.</i>: Mechanical Circulatory Support Devices for Acute Right Ventricular Failure. <i>Circulation.</i> 2017; <b>136</b>(3): 314–26. <a target=xrefwindow id=d17791e5537 href="http://www.ncbi.nlm.nih.gov/pubmed/28716832">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5540 href="https://doi.org/10.1161/CIRCULATIONAHA.116.025290">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735106703"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5549 class=n-a></a>Guglin M, Zucker MJ, Bazan VM, <i> et al.</i>: Venoarterial ECMO for Adults: JACC Scientific Expert Panel. <i>J Am Coll Cardiol.</i> 2019; <b>73</b>(6): 698–716. <a target=xrefwindow id=d17791e5560 href="http://www.ncbi.nlm.nih.gov/pubmed/30765037">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5563 href="https://doi.org/10.1016/j.jacc.2018.11.038 ">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735106703">Faculty Opinions Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d17791e5576 class=n-a></a>Esposito ML, Kapur NK: Acute mechanical circulatory support for cardiogenic shock: The "door to support" time. <i>F1000Res.</i> 2017; <b>6</b>: 737. <a target=xrefwindow id=d17791e5584 href="http://www.ncbi.nlm.nih.gov/pubmed/28580136">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5587 href="https://doi.org/10.12688/f1000research.11150.1">Publisher Full Text </a> | <a target=xrefwindow id=d17791e5590 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5443341">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735435366"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5599 class=n-a></a>Tehrani BN, Truesdell AG, Sherwood MW, <i> et al.</i>: Standardized Team-Based Care for Cardiogenic Shock. <i>J Am Coll Cardiol.</i> 2019; <b>73</b>(13): 1659–69. <a target=xrefwindow id=d17791e5610 href="http://www.ncbi.nlm.nih.gov/pubmed/30947919">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5613 href="https://doi.org/10.1016/j.jacc.2018.12.084">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735435366">Faculty Opinions Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735676429"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5627 class=n-a></a>Garan AR, Takeda K, Salna M, <i> et al.</i>: Prospective Comparison of a Percutaneous Ventricular Assist Device and Venoarterial Extracorporeal Membrane Oxygenation for Patients With Cardiogenic Shock Following Acute Myocardial Infarction. <i>J Am Heart Assoc.</i> 2019; <b>8</b>(9): e012171. <a target=xrefwindow id=d17791e5638 href="http://www.ncbi.nlm.nih.gov/pubmed/31041870">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5641 href="https://doi.org/10.1161/JAHA.119.012171">Publisher Full Text </a> | <a target=xrefwindow id=d17791e5645 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6512118">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735676429">Faculty Opinions Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d17791e5658 class=n-a></a>Korabathina R, Heffernan KS, Paruchuri V, <i> et al.</i>: The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. <i>Catheter Cardiovasc Interv.</i> 2012; <b>80</b>(4): 593–600. <a target=xrefwindow id=d17791e5669 href="http://www.ncbi.nlm.nih.gov/pubmed/21954053">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5672 href="https://doi.org/10.1002/ccd.23309">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736807065"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5681 class=n-a></a>Subramaniam AV, Barsness GW, Vallabhajosyula S, <i> et al.</i>: Complications of Temporary Percutaneous Mechanical Circulatory Support for Cardiogenic Shock: An Appraisal of Contemporary Literature. <i>Cardiol Ther.</i> 2019; <b>8</b>(2): 211–28. <a target=xrefwindow id=d17791e5692 href="http://www.ncbi.nlm.nih.gov/pubmed/31646440">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5695 href="https://doi.org/10.1007/s40119-019-00152-8">Publisher Full Text </a> | <a target=xrefwindow id=d17791e5699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6828896">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736807065">Faculty Opinions Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d17791e5712 class=n-a></a>Villa G, Katz N, Ronco C, <i> et al.</i>: Extracorporeal Membrane Oxygenation and the Kidney. <i>Cardiorenal Med.</i> 2015; <b>6</b>(1): 50–60. <a target=xrefwindow id=d17791e5723 href="http://www.ncbi.nlm.nih.gov/pubmed/27194996">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5726 href="https://doi.org/10.1159/000439444">Publisher Full Text </a> | <a target=xrefwindow id=d17791e5730 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4698639">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d17791e5739 class=n-a></a>Thiele H, Sick P, Boudriot E, <i> et al.</i>: Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. <i>Eur Heart J.</i> 2005; <b>26</b>(13): 1276–83. <a target=xrefwindow id=d17791e5750 href="http://www.ncbi.nlm.nih.gov/pubmed/15734771">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5753 href="https://doi.org/10.1093/eurheartj/ehi161">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d17791e5762 class=n-a></a>Burkhoff D, Cohen H, Brunckhorst C, <i> et al.</i>: A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. <i>Am Heart J.</i> 2006; <b>152</b>(3): 469.e1–8. <a target=xrefwindow id=d17791e5773 href="http://www.ncbi.nlm.nih.gov/pubmed/16923414">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5776 href="https://doi.org/10.1016/j.ahj.2006.05.031">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/1147861"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5786 class=n-a></a>Seyfarth M, Sibbing D, Bauer I, <i> et al.</i>: A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction. <i>J Am Coll Cardiol.</i> 2008; <b>52</b>(19): 1584–8. <a target=xrefwindow id=d17791e5797 href="http://www.ncbi.nlm.nih.gov/pubmed/19007597">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5800 href="https://doi.org/10.1016/j.jacc.2008.05.065">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/1147861">Faculty Opinions Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d17791e5813 class=n-a></a>Ouweneel DM, Eriksen E, Sjauw KD, <i> et al.</i>: Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. <i>J Am Coll Cardiol.</i> 2017; <b>69</b>(3): 278–87. <a target=xrefwindow id=d17791e5824 href="http://www.ncbi.nlm.nih.gov/pubmed/27810347">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5827 href="https://doi.org/10.1016/j.jacc.2016.10.022">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736961014"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5836 class=n-a></a>Bochaton T, Huot L, Elbaz M, <i> et al.</i>: Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study. <i>Arch Cardiovasc Dis.</i> 2020; <b>113</b>(4): 237–43. <a target=xrefwindow id=d17791e5847 href="http://www.ncbi.nlm.nih.gov/pubmed/31740272">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5850 href="https://doi.org/10.1016/j.acvd.2019.10.005">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736961014">Faculty Opinions Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735752454"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5863 class=n-a></a>Brunner S, Guenther SPW, Lackermair K, <i> et al.</i>: Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction. <i>J Am Coll Cardiol.</i> 2019; <b>73</b>(18): 2355–7. <a target=xrefwindow id=d17791e5874 href="http://www.ncbi.nlm.nih.gov/pubmed/31072581">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5877 href="https://doi.org/10.1016/j.jacc.2019.02.044">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735752454">Faculty Opinions Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d17791e5890 class=n-a></a>Pahuja M, Chehab O, Ranka S, <i> et al.</i>: Incidence and clinical outcomes of stroke in ST ‐elevation myocardial infarction and cardiogenic shock. <i>Catheter Cardiovasc Interv.</i> 2020. <a target=xrefwindow id=d17791e5898 href="http://www.ncbi.nlm.nih.gov/pubmed/32352638">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5901 href="https://doi.org/10.1002/ccd.28919">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d17791e5910 class=n-a></a>Pahuja M, Ranka S, Chehab O, <i> et al.</i>: Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock. <i>Catheter Cardiovasc Interv.</i> 2020. <a target=xrefwindow id=d17791e5918 href="http://www.ncbi.nlm.nih.gov/pubmed/32473083">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5921 href="https://doi.org/10.1002/ccd.29003">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735234120"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5931 class=n-a></a>Schrage B, Ibrahim K, Loehn T, <i> et al.</i>: Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. <i>Circulation.</i> 2019; <b>139</b>(10): 1249–58. <a target=xrefwindow id=d17791e5942 href="http://www.ncbi.nlm.nih.gov/pubmed/30586755">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5945 href="https://doi.org/10.1161/CIRCULATIONAHA.118.036614">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735234120">Faculty Opinions Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736928475"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5958 class=n-a></a>Amin AP, Spertus JA, Curtis JP, <i> et al.</i>: The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. <i>Circulation.</i> 2020; <b>141</b>(4): 273–84. <a target=xrefwindow id=d17791e5969 href="http://www.ncbi.nlm.nih.gov/pubmed/31735078">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5972 href="https://doi.org/10.1161/CIRCULATIONAHA.119.044007">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736928475">Faculty Opinions Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737343723"><span class="faculty-opinion-icon small"></span></a><a name=d17791e5985 class=n-a></a>Dhruva SS, Ross JS, Mortazavi BJ, <i> et al.</i>: Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. <i>JAMA.</i> 2020; <b>10</b>: e200254. <a target=xrefwindow id=d17791e5996 href="http://www.ncbi.nlm.nih.gov/pubmed/32040163">PubMed Abstract </a> | <a target=xrefwindow id=d17791e5999 href="https://doi.org/10.1001/jama.2020.0254">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6003 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7042879">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737343723">Faculty Opinions Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d17791e6016 class=n-a></a>Udesen NJ, Møller JE, Lindholm MG, <i> et al.</i>: Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. <i>Am Heart J.</i> 2019; <b>214</b>: 60–8. <a target=xrefwindow id=d17791e6027 href="http://www.ncbi.nlm.nih.gov/pubmed/31176289">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6030 href="https://doi.org/10.1016/j.ahj.2019.04.019">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d17791e6039 class=n-a></a>Sotomi Y, Sato N, Kajimoto K, <i> et al.</i>: Impact of pulmonary artery catheter on outcome in patients with acute heart failure syndromes with hypotension or receiving inotropes: From the ATTEND Registry. <i>Int J Cardiol.</i> 2014; <b>172</b>(1): 165–72. <a target=xrefwindow id=d17791e6050 href="http://www.ncbi.nlm.nih.gov/pubmed/24447746">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6053 href="https://doi.org/10.1016/j.ijcard.2013.12.174">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735339465"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6062 class=n-a></a>Hernandez GA, Lemor A, Blumer V, <i> et al.</i>: Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock. <i>J Card Fail.</i> 2019; <b>25</b>(5): 364–71. <a target=xrefwindow id=d17791e6073 href="http://www.ncbi.nlm.nih.gov/pubmed/30858119">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6076 href="https://doi.org/10.1016/j.cardfail.2019.03.004">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735339465">Faculty Opinions Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732337846"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6090 class=n-a></a>Basir MB, Schreiber T, Dixon S, <i> et al.</i>: Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. <i>Catheter Cardiovasc Interv.</i> 2018; <b>91</b>(3): 454–61. <a target=xrefwindow id=d17791e6101 href="http://www.ncbi.nlm.nih.gov/pubmed/29266676">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6104 href="https://doi.org/10.1002/ccd.27427">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732337846">Faculty Opinions Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737676880"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6117 class=n-a></a>Vallabhajosyula S, Shankar A, Patlolla SH, <i> et al.</i>: Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock. <i>ESC Heart Fail.</i> 2020; <b>7</b>(3): 1234–45. <a target=xrefwindow id=d17791e6128 href="http://www.ncbi.nlm.nih.gov/pubmed/32239806">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6131 href="https://doi.org/10.1002/ehf2.12652">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6135 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7261549">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737676880">Faculty Opinions Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d17791e6148 class=n-a></a>Kapur NK, Hirst C, Zisa D: Advances in Vascular Post-Closure With Impella. <i> Cardiovasc Revasc Med.</i> 2019; <b>20</b>(2): 94–5. <a target=xrefwindow id=d17791e6156 href="http://www.ncbi.nlm.nih.gov/pubmed/30799048">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6159 href="https://doi.org/10.1016/j.carrev.2019.01.016">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736025861"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6168 class=n-a></a>Alushi B, Douedari A, Froehlig G, <i> et al.</i>: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. <i>Open Heart.</i> 2019; <b>6</b>(1): e000987. <a target=xrefwindow id=d17791e6179 href="http://www.ncbi.nlm.nih.gov/pubmed/31218000">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6182 href="https://doi.org/10.1136/openhrt-2018-000987">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6186 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6546200">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736025861">Faculty Opinions Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/738326515"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6199 class=n-a></a>Pieri M, Sorrentino T, Oppizzi M, <i> et al.</i>: The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. <i>J Interv Cardiol.</i> 2018; <b>31</b>(6): 717–24. <a target=xrefwindow id=d17791e6210 href="http://www.ncbi.nlm.nih.gov/pubmed/30460719">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6213 href="https://doi.org/10.1111/joic.12569">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/738326515">Faculty Opinions Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d17791e6226 class=n-a></a>Ferguson JJ, Cohen M, Freedman RJ, <i> et al.</i>: The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. <i>J Am Coll Cardiol.</i> 2001; <b>38</b>(5): 1456–62. <a target=xrefwindow id=d17791e6237 href="http://www.ncbi.nlm.nih.gov/pubmed/11691523">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6240 href="https://doi.org/10.1016/s0735-1097(01)01553-4">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d17791e6250 class=n-a></a>Cohen M, Urban P, Christenson JT, <i> et al.</i>: Intra-aortic balloon counterpulsation in US and non-US centres: Results of the Benchmark Registry. <i>Eur Heart J.</i> 2003; <b>24</b>(19): 1763–70. <a target=xrefwindow id=d17791e6261 href="http://www.ncbi.nlm.nih.gov/pubmed/14522572">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6264 href="https://doi.org/10.1016/j.ehj.2003.07.002">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d17791e6273 class=n-a></a>Stone GW, Ohman EM, Miller MF, <i> et al.</i>: Contemporary Utilization and Outcomes of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction: The Benchmark Registry. <i>J Am Coll Cardiol.</i> 2003; <b>41</b>(11): 1940–5. <a target=xrefwindow id=d17791e6284 href="http://www.ncbi.nlm.nih.gov/pubmed/12798561">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6287 href="https://doi.org/10.1016/s0735-1097(03)00400-5">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d17791e6296 class=n-a></a>Siriwardena M, Pilbrow A, Frampton C, <i> et al.</i>: Complications of intra-aortic balloon pump use: Does the final position of the IABP tip matter? <i>Anaesth Intensive Care.</i> 2015; <b>43</b>(1): 66–73. <a target=xrefwindow id=d17791e6307 href="http://www.ncbi.nlm.nih.gov/pubmed/25579291">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6310 href="https://doi.org/10.1177/0310057X1504300110">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d17791e6319 class=n-a></a>Cohen M, Dawson MS, Kopistansky C, <i> et al.</i>: Sex and other predictors of intra-aortic balloon counterpulsation—related complications: Prospective study of 1119 consecutive patients. <i>Am Heart J.</i> 2000; <b>139</b>(2 Pt 1): 282–7. <a target=xrefwindow id=d17791e6330 href="http://www.ncbi.nlm.nih.gov/pubmed/10650301">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6333 href="https://doi.org/10.1067/mhj.2000.101489">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d17791e6342 class=n-a></a>Valente S, Lazzeri C, Chiostri M, <i> et al.</i>: Intra-aortic balloon pump in intensive cardiac care: A registry in Florence. <i>Int J Cardiol.</i> 2011; <b>146</b>(2): 238–9. <a target=xrefwindow id=d17791e6353 href="http://www.ncbi.nlm.nih.gov/pubmed/21093943">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6356 href="https://doi.org/10.1016/j.ijcard.2010.10.044">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d17791e6365 class=n-a></a>Davidavicius G, Godino C, Shannon J, <i> et al.</i>: Incidence of Overall Bleeding in Patients Treated With Intra-Aortic Balloon Pump During Percutaneous Coronary Intervention: 12-year Milan Experience. <i>JACC Cardiovasc Interv.</i> 2012; <b>5</b>(3): 350–7. <a target=xrefwindow id=d17791e6376 href="http://www.ncbi.nlm.nih.gov/pubmed/22440503">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6379 href="https://doi.org/10.1016/j.jcin.2011.12.012">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d17791e6389 class=n-a></a>Ternus BW, Jentzer JC, El Sabbagh A, <i> et al.</i>: Percutaneous Mechanical Circulatory Support for Cardiac Disease: Temporal Trends in Use and Complications Between 2009 and 2015. <i>J Invasive Cardiol.</i> 2017; <b>29</b>(9): 309–13. <a target=xrefwindow id=d17791e6400 href="http://www.ncbi.nlm.nih.gov/pubmed/28706127">PubMed Abstract </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d17791e6409 class=n-a></a>Schwartz BG, Ludeman DJ, Mayeda GS, <i> et al.</i>: Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience. <i>Cardiol Res.</i> 2012; <b>3</b>(2): 54–66. <a target=xrefwindow id=d17791e6420 href="http://www.ncbi.nlm.nih.gov/pubmed/28348673">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6423 href="https://doi.org/ 10.4021/cr121w">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6427 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5358142">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d17791e6436 class=n-a></a>Mackenzie DJ, Wagner WH, Kulber DA, <i> et al.</i>: Vascular complications of the intra-aortic balloon pump. <i>Am J Surg.</i> 1992; <b>164</b>(5): 517–21. <a target=xrefwindow id=d17791e6447 href="http://www.ncbi.nlm.nih.gov/pubmed/1443380">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6450 href="https://doi.org/10.1016/s0002-9610(05)81192-4">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734377261"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6459 class=n-a></a>Özen Y, Aksut M, Cekmecelioglu D, <i> et al.</i>: Intra-aortic balloon pump experience: A single center study comparing with and without sheath insertion. <i>J Cardiovasc Thorac Res.</i> 2018; <b>10</b>(3): 144–8. <a target=xrefwindow id=d17791e6470 href="http://www.ncbi.nlm.nih.gov/pubmed/30386534">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6473 href="https://doi.org/10.15171/jcvtr.2018.23">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6477 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6203873">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734377261">Faculty Opinions Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d17791e6490 class=n-a></a>Arceo A, Urban P, Dorsaz PA, <i> et al.</i>: In-Hospital Complications of Percutaneous Intraaortic Balloon Counterpulsation. <i>Angiology.</i> 2016; <b>54</b>(5): 577–85. <a target=xrefwindow id=d17791e6501 href="http://www.ncbi.nlm.nih.gov/pubmed/14565633">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6504 href="https://doi.org/10.1177/000331970305400507">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d17791e6513 class=n-a></a>Dick P, Mlekusch W, Delle-Karth G, <i> et al.</i>: Decreasing incidence of critical limb ischemia after intra-aortic balloon pump counterpulsation. <i>Angiology.</i> 2009; <b>60</b>(2): 235–41. <a target=xrefwindow id=d17791e6524 href="http://www.ncbi.nlm.nih.gov/pubmed/18599494">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6527 href="https://doi.org/10.1177/0003319708319782">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d17791e6537 class=n-a></a>Eltchaninoff H, Dimas AP, Whitlow PL: Complications associated with percutaneous placement and use of intraaortic balloon counterpulsation. <i>Am J Cardiol.</i> 1993; <b>71</b>(4): 328–32. <a target=xrefwindow id=d17791e6545 href="http://www.ncbi.nlm.nih.gov/pubmed/8427177">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6548 href="https://doi.org/10.1016/0002-9149(93)90800-r">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d17791e6557 class=n-a></a>Meisel S, Shochat M, Sheikha SA, <i> et al.</i>: Utilization of low-profile intra-aortic balloon catheters inserted by the sheathless technique in acute cardiac patients: Clinical efficacy with a very low complication rate. <i>Clin Cardiol.</i> 2004; <b>27</b>(11): 600–4. <a target=xrefwindow id=d17791e6568 href="http://www.ncbi.nlm.nih.gov/pubmed/15562927">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6571 href="https://doi.org/10.1002/clc.4960271104">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6575 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6654062">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d17791e6584 class=n-a></a>Annamalai SK, Esposito ML, Jorde L, <i> et al.</i>: The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. <i>J Card Fail.</i> 2018; <b>24</b>(10): 706–10. <a target=xrefwindow id=d17791e6595 href="http://www.ncbi.nlm.nih.gov/pubmed/30244180">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6598 href="https://doi.org/10.1016/j.cardfail.2018.09.007">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727617160"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6607 class=n-a></a>O'Neill WW, Schreiber T, Wohns DHW, <i> et al.</i>: The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry. <i>J Interv Cardiol.</i> 2014; <b>27</b>(1): 1–11. <a target=xrefwindow id=d17791e6618 href="http://www.ncbi.nlm.nih.gov/pubmed/24329756">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6621 href="https://doi.org/10.1111/joic.12080">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6625 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4238821">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727617160">Faculty Opinions Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735744456"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6638 class=n-a></a>Jensen PB, Kann SH, Veien KT, <i> et al.</i>: Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock. <i>Eur Heart J Acute Cardiovasc Care.</i> 2018; <b>7</b>(1): 53–61. <a target=xrefwindow id=d17791e6649 href="http://www.ncbi.nlm.nih.gov/pubmed/29148290">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6652 href="https://doi.org/10.1177/2048872617743194">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735744456">Faculty Opinions Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732821301"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6665 class=n-a></a>Karatolios K, Chatzis G, Markus B, <i> et al.</i>: Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest. <i>Resuscitation.</i> 2018; <b>126</b>: 104–10. <a target=xrefwindow id=d17791e6676 href="http://www.ncbi.nlm.nih.gov/pubmed/29522829">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6679 href="https://doi.org/10.1016/j.resuscitation.2018.03.008">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732821301">Faculty Opinions Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736303880"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6693 class=n-a></a>Karami M, den Uil CA, Ouweneel DM, <i> et al.</i>: Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO. <i>Eur Heart J Acute Cardiovasc Care.</i> 2020; <b>9</b>(2): 164–72. <a target=xrefwindow id=d17791e6704 href="http://www.ncbi.nlm.nih.gov/pubmed/31353918">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6707 href="https://doi.org/10.1177/2048872619865891">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736303880">Faculty Opinions Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d17791e6720 class=n-a></a>Basir MB, Kapur NK, Patel K, <i> et al.</i>: Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative. <i>Catheter Cardiovasc Interv.</i> 2019; <b>93</b>(7): 1173–83. <a target=xrefwindow id=d17791e6731 href="http://www.ncbi.nlm.nih.gov/pubmed/31025538">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6734 href="https://doi.org/10.1002/ccd.28307">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735351091"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6743 class=n-a></a>Kaki A, Blank N, Alraies MC, <i> et al.</i>: Axillary Artery Access for Mechanical Circulatory Support Devices in Patients With Prohibitive Peripheral Arterial Disease Presenting With Cardiogenic Shock. <i>Am J Cardiol.</i> 2019; <b>123</b>(10): 1715–21. <a target=xrefwindow id=d17791e6754 href="http://www.ncbi.nlm.nih.gov/pubmed/30879608">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6757 href="https://doi.org/10.1016/j.amjcard.2019.02.033">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735351091">Faculty Opinions Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d17791e6770 class=n-a></a>Lauten A, Engström AE, Jung C, <i> et al.</i>: Percutaneous Left-Ventricular Support With the Impella-2.5-assist Device in Acute Cardiogenic Shock: Results of the Impella-EUROSHOCK-registry. <i>Circ Heart Fail.</i> 2013; <b>6</b>(1): 23–30. <a target=xrefwindow id=d17791e6781 href="http://www.ncbi.nlm.nih.gov/pubmed/23212552">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6784 href="https://doi.org/10.1161/CIRCHEARTFAILURE.112.967224">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734383003"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6793 class=n-a></a>Ouweneel DM, de Brabander J, Karami M, <i> et al.</i>: Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. <i>Eur Heart J Acute Cardiovasc Care.</i> 2019; <b>8</b>(4): 338–49. <a target=xrefwindow id=d17791e6804 href="http://www.ncbi.nlm.nih.gov/pubmed/30403366">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6807 href="https://doi.org/10.1177/2048872618805486">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6811 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6616211">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734383003">Faculty Opinions Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d17791e6824 class=n-a></a>Badiye AP, Hernandez GA, Novoa I, <i> et al.</i>: Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device. <i> ASAIO J.</i> 2016; <b>62</b>(1): 11–4. <a target=xrefwindow id=d17791e6835 href="http://www.ncbi.nlm.nih.gov/pubmed/26418208">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6838 href="https://doi.org/10.1097/MAT.0000000000000290">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d17791e6848 class=n-a></a>Esposito ML, Morine KJ, Annamalai SK, <i> et al.</i>: Increased Plasma-Free Hemoglobin Levels Identify Hemolysis in Patients With Cardiogenic Shock and a Trans valvular Micro-Axial Flow Pump. <i>Artif Organs.</i> 2019; <b>43</b>(2): 125–31. <a target=xrefwindow id=d17791e6859 href="http://www.ncbi.nlm.nih.gov/pubmed/30216467">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6862 href="https://doi.org/10.1111/aor.13319">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d17791e6871 class=n-a></a>Lamarche Y, Cheung A, Ignaszewski A, <i> et al.</i>: Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. <i>J Thorac Cardiovasc Surg.</i> 2011; <b>142</b>(1): 60–5. <a target=xrefwindow id=d17791e6882 href="http://www.ncbi.nlm.nih.gov/pubmed/20880553">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6885 href="https://doi.org/10.1016/j.jtcvs.2010.07.075">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d17791e6894 class=n-a></a>Anderson M, Morris DL, Tang D, <i> et al.</i>: Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device. <i>J Heart Lung Transplant.</i> 2018; <b>37</b>(12): 1448–58. <a target=xrefwindow id=d17791e6905 href="http://www.ncbi.nlm.nih.gov/pubmed/30241890">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6908 href="https://doi.org/10.1016/j.healun.2018.08.001">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d17791e6917 class=n-a></a>Chamogeorgakis T, Rafael A, Shafii AE, <i> et al.</i>: Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock? <i>ASAIO J.</i> 2013; <b>59</b>(6): 607–11. <a target=xrefwindow id=d17791e6928 href="http://www.ncbi.nlm.nih.gov/pubmed/24088905">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6931 href="https://doi.org/10.1097/MAT.0b013e3182a8baf7">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d17791e6940 class=n-a></a>Hoefer D, Ruttmann E, Poelzl G, <i> et al.</i>: Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. <i>Ann Thorac Surg.</i> 2006; <b>82</b>: 28–33. <a target=xrefwindow id=d17791e6951 href="http://www.ncbi.nlm.nih.gov/pubmed/16798182">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6954 href="https://doi.org/ 10.1016/j.athoracsur.2006.02.056">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735313328"><span class="faculty-opinion-icon small"></span></a><a name=d17791e6963 class=n-a></a>Koerner MM, Harper MD, Gordon CK, <i> et al.</i>: Adult cardiac veno-arterial extracorporeal life support (VA-ECMO): Prevention and management of acute complications. <i>Ann Cardiothorac Surg.</i> 2019; <b>8</b>(1): 66–75. <a target=xrefwindow id=d17791e6974 href="http://www.ncbi.nlm.nih.gov/pubmed/30854314">PubMed Abstract </a> | <a target=xrefwindow id=d17791e6977 href="https://doi.org/10.21037/acs.2018.12.09">Publisher Full Text </a> | <a target=xrefwindow id=d17791e6981 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6379202">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735313328">Faculty Opinions Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d17791e6995 class=n-a></a>Lorusso R, Barili F, Di Mauro M, <i> et al.</i>: In-Hospital Neurologic Complications in Adult Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry. <i>Crit Care Med.</i> 2016; <b>44</b>(10): e964–e972. <a target=xrefwindow id=d17791e7006 href="http://www.ncbi.nlm.nih.gov/pubmed/27340754">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7009 href="https://doi.org/10.1097/CCM.0000000000001865">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d17791e7018 class=n-a></a>Kolla S, Lee WA, Hirschl RB, <i> et al.</i>: Extracorporeal Life Support for Cardiovascular Support in Adults. <i>ASAIO J.</i> 1996; <b>42</b>(5): M809–818. <a target=xrefwindow id=d17791e7029 href="http://www.ncbi.nlm.nih.gov/pubmed/8944996">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7032 href="https://doi.org/10.1097/00002480-199609000-00103">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736498248"><span class="faculty-opinion-icon small"></span></a><a name=d17791e7041 class=n-a></a>Gulkarov I, Bobka T, Elmously A, <i> et al.</i>: The Effect of Acute Limb Ischemia on Mortality in Patients Undergoing Femoral Venoarterial Extracorporeal Membrane Oxygenation. <i>Ann Vasc Surg.</i> 2020; <b>62</b>: 318–25. <a target=xrefwindow id=d17791e7052 href="http://www.ncbi.nlm.nih.gov/pubmed/31449945">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7055 href="https://doi.org/10.1016/j.avsg.2019.06.012">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736498248">Faculty Opinions Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734877696"><span class="faculty-opinion-icon small"></span></a><a name=d17791e7068 class=n-a></a>Yau P, Xia Y, Shariff S, <i> et al.</i>: Factors Associated with Ipsilateral Limb Ischemia in Patients Undergoing Femoral Cannulation Extracorporeal Membrane Oxygenation. <i>Ann Vasc Surg.</i> 2019; <b>54</b>: 60–5. <a target=xrefwindow id=d17791e7079 href="http://www.ncbi.nlm.nih.gov/pubmed/30217709">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7082 href="https://doi.org/10.1016/j.avsg.2018.08.073">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734877696">Faculty Opinions Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d17791e7095 class=n-a></a>Avalli L, Sangalli F, Migliari M, <i> et al.</i>: Early vascular complications after percutaneous cannulation for extracorporeal membrane oxygenation for cardiac assist. <i>Minerva Anestesiol.</i> 2016; <b>82</b>(1): 36–43. <a target=xrefwindow id=d17791e7106 href="http://www.ncbi.nlm.nih.gov/pubmed/25907578">PubMed Abstract </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d17791e7115 class=n-a></a>Wong JK, Melvin AL, Joshi DJ, <i> et al.</i>: Cannulation-Related Complications on Veno-Arterial Extracorporeal Membrane Oxygenation: Prevalence and Effect on Mortality. <i>Artif Organs.</i> 2017; <b>41</b>(9): 827–34. <a target=xrefwindow id=d17791e7126 href="http://www.ncbi.nlm.nih.gov/pubmed/28589655">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7129 href="https://doi.org/10.1111/aor.12880">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732441215"><span class="faculty-opinion-icon small"></span></a><a name=d17791e7139 class=n-a></a>Ranney DN, Benrashid E, Meza JM, <i> et al.</i>: Vascular Complications and Use of a Distal Perfusion Cannula in Femorally Cannulated Patients on Extracorporeal Membrane Oxygenation. <i>ASAIO J.</i> 2018; <b>64</b>(3): 328–33. <a target=xrefwindow id=d17791e7150 href="http://www.ncbi.nlm.nih.gov/pubmed/28901993">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7153 href="https://doi.org/10.1097/MAT.0000000000000656">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732441215">Faculty Opinions Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d17791e7166 class=n-a></a>Foley PJ, Morris RJ, Woo EY, <i> et al.</i>: Limb ischemia during femoral cannulation for cardiopulmonary support. <i>J Vasc Surg.</i> 2010; <b>52</b>(4): 850–3. <a target=xrefwindow id=d17791e7177 href="http://www.ncbi.nlm.nih.gov/pubmed/20615644">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7180 href="https://doi.org/10.1016/j.jvs.2010.05.012">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d17791e7189 class=n-a></a>Lamb KM, DiMuzio PJ, Johnson A, <i> et al.</i>: Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation. <i>J Vasc Surg.</i> 2017; <b>65</b>(4): 1074–9. <a target=xrefwindow id=d17791e7200 href="http://www.ncbi.nlm.nih.gov/pubmed/28342510">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7203 href="https://doi.org/10.1016/j.jvs.2016.10.059">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d17791e7212 class=n-a></a>Belle L, Mangin L, Bonnet H, <i> et al.</i>: Emergency extracorporeal membrane oxygenation in a hospital without on-site cardiac surgical facilities. <i>EuroIntervention.</i> 2012; <b>8</b>(3): 375–82. <a target=xrefwindow id=d17791e7223 href="http://www.ncbi.nlm.nih.gov/pubmed/22829512">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7226 href="https://doi.org/10.4244/EIJV8I3A57">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d17791e7235 class=n-a></a>Bermudez CA, Rocha RV, Toyoda Y, <i> et al.</i>: Extracorporeal Membrane Oxygenation for Advanced Refractory Shock in Acute and Chronic Cardiomyopathy. <i>Ann Thorac Surg.</i> 2011; <b>92</b>(6): 2125–31. <a target=xrefwindow id=d17791e7246 href="http://www.ncbi.nlm.nih.gov/pubmed/21982150">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7249 href="https://doi.org/10.1016/j.athoracsur.2011.07.029">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d17791e7258 class=n-a></a>Kim H, Lim SH, Hong J, <i> et al.</i>: Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. <i>Resuscitation.</i> 2012; <b>83</b>(8): 971–5. <a target=xrefwindow id=d17791e7269 href="http://www.ncbi.nlm.nih.gov/pubmed/22322287">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7272 href="https://doi.org/10.1016/j.resuscitation.2012.01.037">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d17791e7282 class=n-a></a>Esper SA, Bermudez C, Dueweke EJ, <i> et al.</i>: Extracorporeal membrane oxygenation support in acute coronary syndromes complicated by cardiogenic shock. <i>Catheter Cardiovasc Interv.</i> 2015; <b>86</b>(Suppl 1): S45–S50. <a target=xrefwindow id=d17791e7293 href="http://www.ncbi.nlm.nih.gov/pubmed/25639707">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7296 href="https://doi.org/10.1002/ccd.25871">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d17791e7305 class=n-a></a>Loforte A, Montalto A, Ranocchi F, <i> et al.</i>: Peripheral extracorporeal membrane oxygenation system as salvage treatment of patients with refractory cardiogenic shock: Preliminary outcome evaluation. <i>Artif Organs.</i> 2012; <b>36</b>(3): E53–61. <a target=xrefwindow id=d17791e7316 href="http://www.ncbi.nlm.nih.gov/pubmed/22352417">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7319 href="https://doi.org/10.1111/j.1525-1594.2011.01423.x">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d17791e7328 class=n-a></a>Moraca RJ, Wanamaker KM, Bailey SH, <i> et al.</i>: Salvage Peripheral Extracorporeal Membrane Oxygenation Using Cobe Revolution® Centrifugal Pump as a Bridge to Decision for Acute Refractory Cardiogenic Shock. <i>J Card Surg.</i> 2012; <b>27</b>(4): 521–7. <a target=xrefwindow id=d17791e7339 href="http://www.ncbi.nlm.nih.gov/pubmed/22616563">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7342 href="https://doi.org/10.1111/j.1540-8191.2012.01467.x">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d17791e7351 class=n-a></a>Pagani FD, Aaronson KD, Swaniker F, <i> et al.</i>: The use of extracorporeal life suppor in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. <i>Ann Thorac Surg.</i> 2001; <b>71</b>(3 Suppl): S77–S81. <a target=xrefwindow id=d17791e7362 href="http://www.ncbi.nlm.nih.gov/pubmed/11265871">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7365 href="https://doi.org/10.1016/s0003-4975(00)02620-5">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d17791e7374 class=n-a></a>Wu MY, Lee MY, Lin CC, <i> et al.</i>: Resuscitation of non-postcardiotomy cardiogenic shock or cardiac arrest with extracorporeal life support: The role of bridging to intervention. <i>Resuscitation.</i> 2012; <b>83</b>(8): 976–81. <a target=xrefwindow id=d17791e7385 href="http://www.ncbi.nlm.nih.gov/pubmed/22269099">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7388 href="https://doi.org/10.1016/j.resuscitation.2012.01.010">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d17791e7397 class=n-a></a>Formica F, Avalli L, Colagrande L, <i> et al.</i>: Extracorporeal membrane oxygenation to support adult patients with cardiac failure: Predictive factors of 30-day mortality. <i>Interact Cardiovasc Thorac Surg.</i> 2010; <b>10</b>(5): 721–6. <a target=xrefwindow id=d17791e7408 href="http://www.ncbi.nlm.nih.gov/pubmed/20123890">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7411 href="https://doi.org/10.1510/icvts.2009.220335">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d17791e7421 class=n-a></a>Batra J, Toyoda N, Goldstone AB, <i> et al.</i>: Extracorporeal Membrane Oxygenation in New York State: Trends, Outcomes, and Implications for Patient Selection. <i>Circ Heart Fail.</i> 2016; <b>9</b>(12): e003179. <a target=xrefwindow id=d17791e7432 href="http://www.ncbi.nlm.nih.gov/pubmed/27940495">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7435 href="https://doi.org/10.1161/CIRCHEARTFAILURE.116.003179">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737617727"><span class="faculty-opinion-icon small"></span></a><a name=d17791e7444 class=n-a></a>Vallabhajosyula S, Bell MR, Sandhu GS, <i> et al.</i>: Complications in Patients with Acute Myocardial Infarction Supported with Extracorporeal Membrane Oxygenation. <i>J Clin Med.</i> 2020; <b>9</b>(3): 839. <a target=xrefwindow id=d17791e7455 href="http://www.ncbi.nlm.nih.gov/pubmed/32204507">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7458 href="https://doi.org/10.3390/jcm9030839">Publisher Full Text </a> | <a target=xrefwindow id=d17791e7462 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7141494">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737617727">Faculty Opinions Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d17791e7475 class=n-a></a>Scheidt S, Wilner G, Mueller H, <i> et al.</i>: Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. <i>N Engl J Med.</i> 1973; <b>288</b>(19): 979–84. <a target=xrefwindow id=d17791e7486 href="http://www.ncbi.nlm.nih.gov/pubmed/4696253">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7489 href="https://doi.org/10.1056/NEJM197305102881901">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d17791e7498 class=n-a></a>Lee L, Bates ER, Pitt B, <i> et al.</i>: Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. <i>Circulation.</i> 1988; <b>78</b>(6): 1345–51. <a target=xrefwindow id=d17791e7509 href="http://www.ncbi.nlm.nih.gov/pubmed/2973377">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7512 href="https://doi.org/10.1161/01.cir.78.6.1345">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/718724938"><span class="faculty-opinion-icon small"></span></a><a name=d17791e7521 class=n-a></a>Hochman JS, Sleeper LA, Webb JG, <i> et al.</i>: Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. <i>N Engl J Med.</i> 1999; <b>341</b>(9): 625–34. <a target=xrefwindow id=d17791e7532 href="http://www.ncbi.nlm.nih.gov/pubmed/10460813">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7535 href="https://doi.org/10.1056/NEJM199908263410901">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/718724938">Faculty Opinions Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d17791e7548 class=n-a></a>Kapur NK, Alkhouli MA, DeMartini TJ, <i> et al.</i>: Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction. <i>Circulation..</i> 2019; <b>139</b>(3): 337–346. <a target=xrefwindow id=d17791e7559 href="http://www.ncbi.nlm.nih.gov/pubmed/30586728">PubMed Abstract </a> | <a target=xrefwindow id=d17791e7562 href="https://doi.org/10.1161/CIRCULATIONAHA.118.038269">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Jul 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-794/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-794/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> The Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, MA, USA<br/> <sup>2</sup> Division of Cardiology, Detroit Medical Center/Wayne State University School of Medicine, Detroit, MI, USA<br/> <p> <div class=margin-bottom> Navin K. Kapur <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Project Administration, Supervision, Writing – Review & Editing </div> <div class=margin-bottom> Evan H. Whitehead <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Resources, Writing – Original Draft Preparation </div> <div class=margin-bottom> Katherine L. Thayer <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Methodology, Writing – Review & Editing </div> <div class=margin-bottom> Mohit Pahuja <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-794/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Jul 2020, 9:794 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.25518.1">https://doi.org/10.12688/f1000research.25518.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Kapur NK <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=28160 data-id=25518 data-downloads="" data-views="" data-scholar="10.12688/f1000research.25518.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-794/v1/pdf?article_uuid=11878dba-7d9e-4da4-8e52-d5a628719075" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.25518.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Kapur NK, Whitehead EH, Thayer KL and Pahuja M. The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):794 (<a href="https://doi.org/10.12688/f1000research.25518.1" target=_blank>https://doi.org/10.12688/f1000research.25518.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=25518 id=mobile-track-article-signin-25518 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/25518?target=/articles/9-794/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=28160 /> <input name=articleId type=hidden value=25518 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Daniel A. Jones</strong>, Department of Cardiology, Barts Heart Centre, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Saraschandra Vallabhajosyula</strong>, Department of Cardiovascular Medicine, Mayo Clinic, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Jul 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-794/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-794/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=72301-67458></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=72302-67459></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-794/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Jul 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Daniel A. Jones</strong>, Department of Cardiology, Barts Heart Centre, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Saraschandra Vallabhajosyula</strong>, Department of Cardiovascular Medicine, Mayo Clinic, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-794/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-794/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The science of safety: complications associated...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-794/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-794/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-794/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Kapur NK et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-794/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-794",
            templates : {
                twitter : "The science of safety: complications associated with the use.... Kapur NK et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-794/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/25518/28160")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "28160");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "67459": 2,
                           "67458": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "8c64e60a-8c92-4225-953e-62bca8c7bc28";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-794.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-794.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-794.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-794.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-794.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>